var title_f31_45_32464="Spring loaded clip applicator";
var content_f31_45_32464=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F53061&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F53061&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Spring-loaded clip applicator for female sterilization",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_45_32464=[""].join("\n");
var outline_f31_45_32464=null;
var title_f31_45_32465="Rectovaginal fistula PI";
var content_f31_45_32465=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F83275&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F83275&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 514px\">",
"   <div class=\"ttl\">",
"    Rectovaginal fistula",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 494px; height: 507px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A rectovaginal fistula is an abnormal connection between the lower part of the large intestine (rectum) and the vagina.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_45_32465=[""].join("\n");
var outline_f31_45_32465=null;
var title_f31_45_32466="Paraneoplastic pemphigus gingiva";
var content_f31_45_32466=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F54382&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F54382&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Paraneoplastic pemphigus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gingival erosions are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_45_32466=[""].join("\n");
var outline_f31_45_32466=null;
var title_f31_45_32467="Dyclonine: Patient drug information";
var content_f31_45_32467=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Dyclonine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/46/26338?source=see_link\">",
"     see \"Dyclonine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?22/61/23506?source=see_link\">",
"     see \"Dyclonine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F163927\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Sucrets&reg; Children's [OTC];",
"     </li>",
"     <li>",
"      Sucrets&reg; Maximum Strength [OTC];",
"     </li>",
"     <li>",
"      Sucrets&reg; Regular Strength [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10014216\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease mouth and throat pain.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10014215\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701999",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to dyclonine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10014220\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696752",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not eat while your mouth feels numb. You may bite your tongue.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10014221\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698241",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mouth irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10014223\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698698",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If signs get worse or last for more than 7 days.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699132",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       When treating a very sore throat, if signs last more than 2 days, or happen with fever, headache, rash, upset stomach, or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699035",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad mouth irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10014218\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695691",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Suck oral lozenge. Do not chew, break, or crush it. Do not swallow it whole.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10014219\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10014224\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10014225\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10983 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-61.234.146.186-543E46505B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_45_32467=[""].join("\n");
var outline_f31_45_32467=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F163927\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014216\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014215\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014220\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014221\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014223\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014218\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014219\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014224\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014225\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?25/46/26338?source=related_link\">",
"      Dyclonine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?22/61/23506?source=related_link\">",
"      Dyclonine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_45_32468="Fluticasone (nasal): Pediatric drug information";
var content_f31_45_32468=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Fluticasone (nasal): Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?30/3/30773?source=see_link\">",
"    see \"Fluticasone (nasal): Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?28/5/28756?source=see_link\">",
"    see \"Fluticasone (nasal): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9349460\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Flonase&reg;;",
"     </li>",
"     <li>",
"      Veramyst&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9349461\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Fluticasone&reg;;",
"     </li>",
"     <li>",
"      Avamys&reg;;",
"     </li>",
"     <li>",
"      Flonase&reg;;",
"     </li>",
"     <li>",
"      ratio-Fluticasone",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F990162\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Corticosteroid, Intranasal",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F990173\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?30/3/30773?source=see_link\">",
"      see \"Fluticasone (nasal): Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     <b>",
"      Seasonal and perennial rhinitis:",
"     </b>",
"     <b>",
"      Note:",
"     </b>",
"     For optimal effects, nasal spray should be used at regular intervals (eg, once or twice daily); however, some adolescent patients &ge;12 years of age and adults with seasonal allergic rhinitis may have effective control of symptoms with prn (as needed) use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Flonase&reg;:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Children &ge;4 years and Adolescents: Initial: 1 spray (50 mcg/spray) to each nostril daily (100 mcg/day); if response is inadequate, give 2 sprays to each nostril daily (200 mcg/day); once symptoms are controlled, reduce dose to 100 mcg/day (1 spray to each nostril daily); maximum dose: 200 mcg/day (4 sprays/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Adults: Initial: 200 mcg/day given as 2 sprays (50 mcg/spray) to each nostril daily or 1 spray to each nostril twice daily; dosage may be reduced to 100 mcg/day (1 spray to each nostril daily) after the first few days if symptoms are controlled; maximum dose: 200 mcg/day (4 sprays/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Veramyst&reg;:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Children 2-11 years: Initial: 1 spray (27.5 mcg/spray) to each nostril daily (55 mcg/day); if response is inadequate, give 2 sprays to each nostril daily (110 mcg/day); once symptoms have been controlled, the dosage may be reduced to 55 mcg/day (1 spray to each nostril daily); maximum dose: 110 mcg/day (4 sprays/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Children &gt;11 years, Adolescents, and Adults: Initial: 2 sprays (27.5 mcg/spray) to each nostril daily (110 mcg/day); once symptoms are controlled, dosage may be reduced to 55 mcg/day (1 spray to each nostril daily); maximum dose: 110 mcg/day (4 sprays/day)",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F242539\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suspension, intranasal, as furoate [spray]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Veramyst&reg;: 27.5 mcg/inhalation (10 g) [contains benzalkonium chloride; 120 metered actuations]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suspension, intranasal, as propionate [spray]: 50 mcg/inhalation (16 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Flonase&reg;: 50 mcg/inhalation (16 g) [contains benzalkonium chloride; 120 metered actuations]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F9349463\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Propionate spray",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F990174\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Shake bottle gently before use; clear nasal passages by blowing nose prior to use. Insert applicator into nostril, keeping bottle upright, and close off the other nostril; breathe in through nose; while inhaling, press pump to release spray. Avoid spraying into eyes. Discard after labeled number of doses has been used, even if bottle is not completely empty.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Flonase&reg;: Prime pump (press 6 times until fine spray appears) prior to first use or if spray unused for &ge;7 days.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Veramyst&reg;: Prime pump (press 6 times until fine spray appears) prior to first use, if spray unused for &gt;30 days, or if cap left off bottle for &ge;5 days.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F10494146\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Flonase&reg;: Store between 4&deg;C to 30&deg;C (39&deg;F to 86&deg;F)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Veramyst&reg;: Store between 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F) in upright position. Do not refrigerate or freeze.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F990163\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Flonase&reg;: Management of seasonal and perennial allergic rhinitis and nonallergic rhinitis (FDA approved in ages &ge;4 years and adults)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Veramyst&reg;: Management of seasonal and perennial allergic rhinitis (FDA approved in ages &ge;2 years and adults)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F9349456\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Flonase&reg; may be confused with Flovent&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Allegro: Brand name for fluticasone [Israel], but also the brand name for frovatriptan [Germany]",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Allegro [Israel] may be confused with Allegra and Allegra-D brand names for fexofenadine and fexofenadine/pseudoephedrine, respectively, [U.S., Canada, and multiple international markets]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F9349492\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Dizziness, fever, headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, diarrhea, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Back pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Asthma symptoms, blood in nasal mucous, bronchitis, cough, epistaxis, nasal ulcer, pharyngitis, pharyngolaryngeal pain, runny nose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Aches and pains, flu-like syndrome",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Alteration or loss of sense of taste and/or smell, anaphylaxis/anaphylactoid reactions, angioedema, AST increased, AV block (second degree), cataracts, conjunctivitis, glaucoma, hypersensitivity reactions, increased intraocular pressure, nasal candidiasis, nasal septal perforation (rare), psychomotor hyperactivity, skin rash, tremor, vaginal candidiasis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F990165\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to fluticasone or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F10494041\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid using higher than recommended dosages; suppression of HPA function, suppression of linear growth (ie, reduction of growth velocity), reduced bone mineral density, or hypercorticism (Cushing's syndrome) may occur; titrate to lowest effective dose. Reduction in growth velocity may occur when corticosteroids are administered to pediatric patients, even at recommended doses via intranasal route (monitor growth). Use fluticasone with extreme caution in patients with respiratory tuberculosis; untreated bacterial, fungal, systemic viral or parasitic infections; or ocular herpes simplex. Localized",
"     <i>",
"      Candida",
"     </i>",
"     infections of the nose and pharynx have been reported rarely; interruption of therapy may be necessary while antifungal therapy is employed. Corticosteroids impair wound healing; avoid use in patients with recent nasal ulcers, nasal surgery, or nasal trauma; allow healing to occur before use. Use of nasal fluticasone in place of systemic corticosteroids may unmask allergies (eg, eczema, rhinitis) that were previously controlled by the systemic corticosteroids. Rare cases of immediate hypersensitivity reactions, nasal septum perforation, increased IOP, glaucoma, or cataracts may occur with intranasal corticosteroids.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F990166\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     HPA suppression or hypercorticism (Cushing's syndrome) may occur with use of higher than recommended doses or at typical doses in susceptible patients. Acute adrenal insufficiency may occur with abrupt withdrawal after long-term use, with stress, or when converting from systemic to topical corticosteroid therapy; withdrawal or discontinuation of corticosteroids should be done carefully; patients with HPA axis suppression may require doses of systemic glucocorticosteroids prior to, during, and after unusual stress (eg, surgery). Immunosuppression may occur; patients may be more susceptible to infections; avoid exposure to chickenpox and measles. Epistaxis may occur.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Potent inhibitors of cytochrome P450 isoenzyme CYP3A4 (eg, ritonavir, ketoconazole) may significantly increase fluticasone serum concentrations and result in systemic corticosteroid effects.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F9349495\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F242533\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cobicistat: May increase the serum concentration of Fluticasone (Nasal). Management: Consider using an alternative nasal corticosteroid when possible, partiularly for longer-term concurrent use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May increase the serum concentration of Fluticasone (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ritonavir: May increase the serum concentration of Fluticasone (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telaprevir: May increase the serum concentration of Fluticasone (Nasal). Management: Concurrent use of telaprevir with inhaled fluticasone is not recommended, unless the risk for excessive systemic corticosteroid effects is outweighed by the potential benefits.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F242534\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F9349487\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have been observed with systemic corticosteroids in animal reproduction studies; teratogenic effects were not observed following administration of fluticasone furoate via inhalation to pregnant rats or rabbits. A decrease in fetal growth has not been observed with inhaled corticosteroid use during pregnancy. Inhaled corticosteroids are recommended for the treatment of allergic rhinitis during pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F990171\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Controls the rate of protein synthesis, depresses the migration of polymorphonuclear leukocytes and fibroblasts, reverses capillary permeability, and stabilizes lysosomal membranes at the cellular level to prevent or control inflammation.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F10494147\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Onset of action: Variable; may occur within 24 hours",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F990177\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?28/5/28756?source=see_link\">",
"      see \"Fluticasone (nasal): Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;display:inline\">",
"     Full response to this medication may not be seen for 2-5 weeks. Use regularly. Do not stop treatment, even if feeling better. Notify physician if condition being treated persists or worsens; do not decrease dose or discontinue without physician approval. Avoid exposure to chickenpox or measles; if exposed, seek medical advice without delay. Report sore mouth or mouth lesions, persistent headache, or nosebleeds to physician; carefully read and follow the patient instructions for use leaflet that accompanies the product.",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F990178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     In a small pediatric study conducted over 1 year, no statistically significant effect on growth velocity or clinically relevant changes in bone mineral density or HPA axis function were observed in children 3-9 years of age receiving fluticasone nasal spray (200 mcg/day; n=56) versus placebo (n=52); effects at higher doses or in susceptible pediatric patients cannot be ruled out",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15932 Version 25.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-194.187.108.93-9EF4B3CCD6-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_45_32468=[""].join("\n");
var outline_f31_45_32468=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9349460\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9349461\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F990162\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F990173\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F242539\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9349463\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F990174\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10494146\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F990163\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9349456\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9349492\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F990165\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10494041\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F990166\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9349495\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F242533\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F242534\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9349487\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F990171\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10494147\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F990177\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F990178\">",
"      Additional Information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/15932\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/15932|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?30/3/30773?source=related_link\">",
"      Fluticasone (nasal): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?28/5/28756?source=related_link\">",
"      Fluticasone (nasal): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?25/32/26120?source=related_link\">",
"      Fluticasone (oral inhalation): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?12/33/12822?source=related_link\">",
"      Fluticasone (oral inhalation): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?24/29/25047?source=related_link\">",
"      Fluticasone (oral inhalation): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?43/19/44340?source=related_link\">",
"      Fluticasone (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?14/54/15204?source=related_link\">",
"      Fluticasone (topical): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?27/7/27764?source=related_link\">",
"      Fluticasone (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_45_32469="Glyburide and metformin: Patient drug information";
var content_f31_45_32469=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Glyburide and metformin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/9/10391?source=see_link\">",
"     see \"Glyburide and metformin: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F176796\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Glucovance&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10022602\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700180",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A small number of people may have more acid in their blood. Metformin may cause this. It may happen in people whose liver or kidneys do not work the right way.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10022604\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691404",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower blood sugar in patients with high blood sugar (diabetes).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10022603\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702209",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to glyburide, metformin, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a sulfa (sulfonamide) allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703190",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Acidic blood problem, drink too much alcohol, fluid loss, kidney disease, or liver disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701053",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are having an x-ray with dye.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10022608\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697808",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Stop this drug for 2 days after you have an x-ray with dye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697748",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use care if you are having surgery, if you have had a heart attack, bad infection, or stroke, or if you are 80 years of age or older and have not had your kidney function tested.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a weak heart, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696699",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful if you have G6PD deficiency. Anemia may happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698422",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check your blood sugar as you have been told by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698495",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have an eye exam and visit the foot doctor every year.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696750",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not drive if your blood sugar has been low. There is a greater chance of you having a crash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10022609\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698210",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low blood sugar may occur. Signs may be dizziness, headache, feeling sleepy, feeling weak, shaking, a fast heartbeat, confusion, hunger, or sweating. Keep hard candies, glucose tablets, liquid glucose, or juice on hand for low blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696432",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bad taste in your mouth. This most often goes back to normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697904",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Too much acid in the blood (lactic acidosis) may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10022611\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very low blood sugar or very high blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699024",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699038",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad muscle pain or weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698656",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling cold.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10022606\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695966",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be used alone or with other high blood sugar (diabetes) drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695907",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug with food.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10022607\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10022612\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10022613\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12515 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.146-E8BDD971E0-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_45_32469=[""].join("\n");
var outline_f31_45_32469=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F176796\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022602\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022604\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022603\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022608\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022609\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022611\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022606\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022607\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022612\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022613\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?10/9/10391?source=related_link\">",
"      Glyburide and metformin: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_45_32470="Doppler diastolic dysfunction";
var content_f31_45_32470=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F72146&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F72146&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 626px\">",
"   <div class=\"ttl\">",
"    Doppler echocardiographic criteria for classification of diastolic function",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 606px; height: 722px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Participants with atrial fibrillation with DT &gt;140 ms, other arrhythmia, fusion of E and A, or in whom diastolic parameters were not obtained, who had only&nbsp;one criterion suggesting moderate or severe diastolic dysfunction, or in whom diastolic parameters were borderline and suggestive of but not diagnostic of abnormality were classified as having indeterminate diastolic function.",
"    <br>",
"     Grade I (mild) diastolic dysfunction is characterized by the impaired relaxation pattern.",
"     <br>",
"      Grade II (moderate) diastolic dysfunction is charaterized by a pseudonormal pattern.",
"      <br>",
"       Grades III and IV (severe) diastolic dysfunction is characterized by a (irreversible and fixed) restrictive pattern.",
"       <div class=\"footnotes\">",
"        E: peak early filling velocity; A: velocity at atrial contraction; DT: deceleration time; Adur: A duration; ARdur: AR duration; S: systolic forward flow; D: diastolic forward flow; AR: pulmonary venous atrial reversal flow; e': velocity of mitral annulus early diastolic motion; a': velocity of mitral annulus motion with atrial systole; DT: mitral E velocity deceleration time.",
"       </div>",
"       <div class=\"reference\">",
"        Reproduced with permission from: Redfield MM, Jacobsen SJ, Burnett JC Jr, et al. Burden of systolic and diastolic ventricular dysfunction in the community: Appreciating the scope of the heart failure epidemic. JAMA 2003; 289:194. Copyright &copy; 2003 American Medical Association. All rights reserved.",
"       </div>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_45_32470=[""].join("\n");
var outline_f31_45_32470=null;
var title_f31_45_32471="Overview of gingivitis and periodontitis in children and adolescents";
var content_f31_45_32471=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of gingivitis and periodontitis in children and adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/45/32471/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/45/32471/contributors\">",
"     Ann Griffen, DDS, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/45/32471/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/45/32471/contributors\">",
"     Dimitris N Tatakis, DDS, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/45/32471/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/45/32471/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/45/32471/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic periodontitis affects most of the adult population to some degree, and it has its incipient beginning in adolescence. Other more serious and aggressive periodontal diseases also are seen occasionally in children, and some of these diseases are signs of systemic diseases or conditions. Definitive diagnosis usually requires a detailed dental examination, including intra-oral radiographs and periodontal probing, but signs can be recognized from visual inspection of the gingival and other oral structures.",
"   </p>",
"   <p>",
"    Periodontal diseases affect the dental supporting structures, primarily the gingiva and alveolar bone (",
"    <a class=\"graphic graphic_figure graphicRef67237 \" href=\"mobipreview.htm?21/27/21939\">",
"     figure 1",
"    </a>",
"    ). They are caused by complex communities of bacteria that grow in a biofilm on the surface of the tooth (dental plaque). Bacteria elicit an inflammatory response that can result in tissue destruction. Both gingivitis and periodontitis occur in children and adolescents. Gingivitis is a reversible dental plaque-induced inflammation limited to the gingiva, and it is common in children as young as five years of age. Periodontitis is usually accompanied by gingivitis but involves irreversible destruction of the supporting tissues surrounding the tooth, including the alveolar bone (",
"    <a class=\"graphic graphic_figure graphicRef67237 \" href=\"mobipreview.htm?21/27/21939\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Some degree of periodontitis is seen in most adults. Almost 15 percent of the adult population is affected by advanced chronic periodontitis, which occurs equally in men and women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/1\">",
"     1",
"    </a>",
"    ] and is the major cause of tooth loss in adults. Although chronic periodontitis often begins in adolescence, progression is slow, and cumulative signs of destruction are usually not noted before young adulthood. The more aggressive and rarer forms of periodontitis do produce destruction that is apparent during childhood. The prevalence of these diseases is probably less than 2 percent of the population. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Aggressive periodontitis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The periodontal examination and the presentation and management of gingivitis and periodontitis in children and adolescents are reviewed here. Other soft tissue lesions and the periodontal manifestations of systemic conditions are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/32/30216?source=see_link\">",
"     \"Soft tissue lesions of the oral cavity in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/60/8137?source=see_link\">",
"     \"Systemic conditions associated with periodontal disease in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PERIODONTAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pediatric healthcare providers should be alert for signs of periodontal disease in children and adolescents. Detailed examination by a dentist is recommended every six months, but several of the signs of periodontitis are apparent on visual inspection. Heavy plaque (",
"    <a class=\"graphic graphic_picture graphicRef66029 \" href=\"mobipreview.htm?11/24/11651\">",
"     picture 1",
"    </a>",
"    ) or calculus deposits (",
"    <a class=\"graphic graphic_picture graphicRef50438 \" href=\"mobipreview.htm?24/46/25313\">",
"     picture 2",
"    </a>",
"    ); enlargement or edema of the gingival tissues; redness, bleeding, or recession of the gingiva; abnormal change in tooth position; and premature tooth mobility or tooth loss are indications for referral for further evaluation. In addition, smoking status (both tobacco and marijuana) should be determined because smoking is a major risk factor for the development of periodontal disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/2-7\">",
"     2-7",
"    </a>",
"    ]. Patients who smoke should be provided with information about the benefits and methods of quitting. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/33/18968?source=see_link&amp;anchor=H2589684#H2589684\">",
"     \"Benefits and risks of smoking cessation\", section on 'Benefits of smoking cessation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/33/41497?source=see_link&amp;anchor=H19#H19\">",
"     \"Management of smoking cessation in adolescents\", section on 'Interventions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Calculus, common in adults, is present in approximately 10 percent of children and one-third of adolescents. The typical locations for calculus are the lingual surface of the mandibular incisors (",
"    <a class=\"graphic graphic_picture graphicRef50438 \" href=\"mobipreview.htm?24/46/25313\">",
"     picture 2",
"    </a>",
"    ) and the buccal surface of the maxillary molars. It can be removed only by professional tooth cleaning and should not be allowed to remain on the teeth because it provides a habitat for the bacteria associated with periodontitis. Semi-annual tooth cleaning is adequate for most children, but a small number of heavy-calculus formers may require more frequent visits.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Normal findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The gingival tissues surrounding the teeth in children should appear pink to reddish pink and be firm and resilient. A slight rolling or rounding around the neck of the tooth is normal (",
"    <a class=\"graphic graphic_picture graphicRef52338 \" href=\"mobipreview.htm?30/51/31551\">",
"     picture 3",
"    </a>",
"    ). The root surface of the tooth should be covered by gingiva (with underlying bone), but very little of the crown should be covered. The tooth surface along the gingival margin (gum line) should be free of visible plaque deposits or calculus. The marginal gingiva should be smooth, and no bleeding should be present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     GINGIVITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Simple gingivitis, characterized by inflammation of the gingival tissues with no loss of attachment or bone (",
"    <a class=\"graphic graphic_picture graphicRef70283 \" href=\"mobipreview.htm?23/40/24192\">",
"     picture 4",
"    </a>",
"    ), is the most common periodontal problem in childhood. Inadequate oral hygiene is the most common cause of gingivitis. Certain local factors, by interfering with oral hygiene, physiology, or homeostasis, can predispose to development of gingivitis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Orthodontic appliances, crowding of teeth, and lingually or labially erupted teeth render achieving adequate oral hygiene difficult (",
"      <a class=\"graphic graphic_picture graphicRef66029 \" href=\"mobipreview.htm?11/24/11651\">",
"       picture 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Chronic mouth breathing can cause localized gingivitis of the exposed gingiva in the maxillary labial area (",
"      <a class=\"graphic graphic_picture graphicRef61062 \" href=\"mobipreview.htm?31/49/32542\">",
"       picture 5",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Eruption of primary and permanent teeth causes local inflammation and erythema (",
"      <a class=\"graphic graphic_picture graphicRef70283 \" href=\"mobipreview.htm?23/40/24192\">",
"       picture 4",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Hormonal changes during puberty and pregnancy (",
"      <a class=\"graphic graphic_picture graphicRef82278 \" href=\"mobipreview.htm?27/6/27744\">",
"       picture 6",
"      </a>",
"      ) cause the gingiva to become inflamed and hypertrophic. Puberty gingivitis is thought to be related to increases in steroid hormones and changes in the subgingival microbiota [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/8,9\">",
"       8,9",
"      </a>",
"      ]. Puberty gingivitis may be severe and may be associated with granulomatous changes (",
"      <a class=\"graphic graphic_picture graphicRef64885 \" href=\"mobipreview.htm?6/34/6689\">",
"       picture 7",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Malnutrition, viral infections, stress, and sleep deprivation can predispose to the development of a very severe and painful form of gingivitis, termed acute necrotizing ulcerative gingivitis. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Acute necrotizing ulcerative gingivitis'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Longstanding gingivitis can result in chronic inflammatory gingival enlargement (",
"    <a class=\"graphic graphic_picture graphicRef81784 \" href=\"mobipreview.htm?4/27/4532\">",
"     picture 8",
"    </a>",
"    ), which is a particularly common occurrence in patients with orthodontic appliances and poor oral hygiene. The gingival enlargement usually will resolve slowly after effective, regular oral hygiene measures are instituted. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/32/30216?source=see_link&amp;anchor=H9#H9\">",
"     \"Soft tissue lesions of the oral cavity in children\", section on 'Gingival overgrowth'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Prevalence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gingivitis is uncommon in young children with early primary dentition. It is present in up to one-half of the population by the age of four to five years. The prevalence of gingivitis increases with age, peaking at close to 100 percent at puberty (approximately 10 years of age in girls and 13 years of age in boys). After puberty, the prevalence declines to 50 percent and remains relatively constant into adulthood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The inflammation responsible for gingivitis occurs in response to the bacteria that live in biofilms at the gingival margin and in the gingival crevice. These biofilm communities are complex, and the specific bacteria responsible for gingivitis have not been definitively identified, but gingivitis does not occur in the absence of plaque, and it resolves when plaque is removed consistently.",
"   </p>",
"   <p>",
"    Young children have less plaque and appear to be less reactive to plaque than are adults; thus gingivitis is an uncommon occurrence in children with early primary dentition. The diminished reaction may be a result of differences in bacterial colonization and developmental changes in the inflammatory response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Clinical findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of gingivitis are those of inflammation, predominantly edema and erythema (",
"    <a class=\"graphic graphic_picture graphicRef70283 \" href=\"mobipreview.htm?23/40/24192\">",
"     picture 4",
"    </a>",
"    ). In severe cases, the gingival tissues may bleed spontaneously from ulcerations in the sulcus. Tissue hypertrophy also may develop if the inflammation is longstanding. Gingivitis can be described as localized or generalized, marginal or diffuse, desquamative, hemorrhagic, and even sometimes suppurative.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Childhood gingivitis is reversible; it is treated through improved oral hygiene. Recommendations for improving oral hygiene are based on observational studies and small clinical trials. They include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The use of an appropriately sized toothbrush (smaller heads and larger handles are helpful for children; brushes labeled for specific age groups are available from several manufacturers)",
"     </li>",
"     <li>",
"      The use of toothpaste and dental floss in flavors that appeal to children",
"     </li>",
"     <li>",
"      Parental supervision and assistance in the oral hygiene routine of children younger than 8 to 10 years of age",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     ACUTE NECROTIZING ULCERATIVE GINGIVITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute necrotizing ulcerative gingivitis (ANUG) is a painful gingivitis with rapid onset, interproximal and marginal soft tissue necrosis, ulceration, and bleeding. It is associated with high oral concentrations of spirochetes and",
"    <em>",
"     Prevotella intermedia",
"    </em>",
"    . In North America and Europe, the incidence of ANUG peaks in the late teens and early twenties; however, in less developed countries, ANUG commonly occurs in young children. Factors that predispose to development of ANUG include smoking, malnutrition, viral infections, stress, and sleep deprivation. Standard treatment involves local debridement, which usually produces rapid resolution. A number of chemical agents have been tested in small trials, and none appear to surpass simple debridement. Antibiotic therapy with penicillin or",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?20/59/21425?source=see_link\">",
"     metronidazole",
"    </a>",
"    may be indicated in patients with fever.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     PERIODONTITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Periodontitis is characterized by gingival inflammation with accompanying (and irreversible) loss of supportive connective tissues, including alveolar bone (",
"    <a class=\"graphic graphic_figure graphicRef67237 \" href=\"mobipreview.htm?21/27/21939\">",
"     figure 1",
"    </a>",
"    ). It results in apical migration of the attachment of the epithelium to the tooth surface and the development of a \"periodontal pocket.\"",
"   </p>",
"   <p>",
"    Several distinct forms of periodontitis are recognized, with chronic periodontitis being the most common. Chronic periodontitis usually is not diagnosed until adulthood, although it may have its onset in childhood. Other more aggressive forms of periodontitis, although more rare, are diagnosed most frequently initially in the pediatric population. They include localized aggressive periodontitis, generalized aggressive periodontitis, and periodontitis associated with systemic conditions. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/60/8137?source=see_link\">",
"     \"Systemic conditions associated with periodontal disease in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chronic periodontitis and most other forms of periodontitis are caused by bacteria residing in biofilms in the gingival sulcus, and therapy is aimed at eradicating or reducing the numbers of these bacteria. Approximately 700 species of bacteria commonly reside in the sulcus, some of them not yet cultivable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/13\">",
"     13",
"    </a>",
"    ]. Several species that have been associated consistently with chronic periodontitis include",
"    <em>",
"     Porphyromonas gingivalis",
"    </em>",
"    ,",
"    <em>",
"     Bacteroides forsythus",
"    </em>",
"    , and",
"    <em>",
"     Treponema denticola",
"    </em>",
"    . These bacteria have been detected regularly in asymptomatic children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/14,15\">",
"     14,15",
"    </a>",
"    ], but they do not appear to establish stable colonization, and researchers assume they do not occur in high numbers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Epidemiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Loss of periodontal attachment is a common occurrence in adults, with most adults being affected by what was previously called \"adult-onset\" periodontitis, a chronic and slowly progressing form of the disease. However, with increased focus on early detection and prevention of dental disease, incipient periodontitis is being identified in greater numbers of children. When careful measurements were taken, 20 percent of 14- to 17-year-old adolescents in the United States were found to have attachment loss of at least 2 mm at one or more sites [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/16\">",
"     16",
"    </a>",
"    ], indicating \"adult-onset\" periodontitis often begins in adolescence, and leading to a change in nomenclature from \"adult periodontitis\" to \"chronic periodontitis\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The number and severity of affected sites increases steadily with age as the damage accumulates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/10\">",
"     10",
"    </a>",
"    ], but the rate of progression of disease in chronic periodontitis is similar regardless of age. Smoking is a major risk factor for developing chronic periodontitis. Other, more aggressive forms of periodontitis are more unusual, but they are seen most commonly in the pediatric population. Localized aggressive periodontitis (previously called localized juvenile periodontitis [LJP] and localized prepubertal periodontitis) are described below. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Localized aggressive'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In addition, childhood periodontitis is associated with several systemic conditions, including Down syndrome, neutropenia, leukocyte adhesion deficiency, leukemia, Langerhans cell histiocytosis, diabetes mellitus, hypophosphatasia, and Papillon-Lef&egrave;vre syndrome. Although many patients with periodontitis are healthy except for subtle abnormalities in host defenses, children with periodontal disease should be evaluated for the above-mentioned conditions, some of which may be serious or even life-threatening [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/60/8137?source=see_link\">",
"     \"Systemic conditions associated with periodontal disease in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of advanced periodontitis include attachment loss, gingival recession, periodontal bone loss, tooth mobility, and tooth loss (",
"    <a class=\"graphic graphic_figure graphicRef67237 \" href=\"mobipreview.htm?21/27/21939\">",
"     figure 1",
"    </a>",
"    ). In the early stages of disease, gingival recession may not be present. Periodontal bone loss can be localized, generalized, horizontal, or vertical. Periodontal disease is episodic; the periods between disease activity and inactivity are unpredictable.",
"   </p>",
"   <p>",
"    In most cases, the presence of early periodontitis in children is not clinically obvious without probing for attachment loss and obtaining radiographs to assess the bone levels around the teeth. Premature tooth mobility or tooth loss is a late sign and may indicate advanced periodontal disease, which may be the presenting sign of a serious systemic condition (",
"    <a class=\"graphic graphic_table graphicRef58443 \" href=\"mobipreview.htm?22/34/23084\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Chronic periodontitis in the early stages responds well to appropriate periodontal therapy, which must include improved oral hygiene. If detected and treated early, it can be arrested in the early stages, when attachment loss is minimal and deep pockets have not developed. The more aggressive forms of periodontitis usually require antibiotic therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Aggressive periodontitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aggressive periodontitis usually affects individuals younger than 35 years of age and is characterized by a rapid rate of bone loss and progression of disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/19\">",
"     19",
"    </a>",
"    ]. Previously, it was called \"early-onset periodontitis.\" Affected individuals are otherwise clinically healthy. This type of periodontitis occurs uncommonly and in association with defects in host immunity and specific etiologic microbial flora [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/20\">",
"     20",
"    </a>",
"    ]. Familial aggregation often is seen.",
"   </p>",
"   <p>",
"    Because it occurs infrequently, the understanding of aggressive periodontitis is incomplete. Further research is needed to better characterize the diagnosis and management of this type of periodontal disease. Aggressive periodontitis occurs in a localized and generalized form. The generalized form usually affects young adults, usually is not seen in childhood, and will not be discussed further here. The localized form affects primarily children and is described in detail below. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/21/18777?source=see_link&amp;anchor=H14#H14\">",
"     \"Gingivitis and periodontitis in adults: Classification and dental treatment\", section on 'Aggressive periodontitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Localized aggressive",
"    </span>",
"    &nbsp;&mdash;&nbsp;Localized aggressive periodontitis (LAP) is characterized by loss of attachment and bone around the permanent incisors and permanent molars [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/21\">",
"     21",
"    </a>",
"    ]. The attachment loss occurs rapidly, at three times the rate of loss in adult-onset disease. The radiographic appearance is distinctive.",
"   </p>",
"   <p>",
"    The prevalence of LAP is estimated to be approximately 1 percent, and in the United States, it is most commonly seen in the African-American population. At least some cases appear to be inherited as an autosomal dominant trait [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. LAP has been linked to a neutrophil chemotactic defect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/24-27\">",
"     24-27",
"    </a>",
"    ]. In addition to the genetic component, LAP clearly is linked to the presence of high numbers of",
"    <em>",
"     Aggregatibacter actinomycetemcomitans",
"    </em>",
"    , and successful treatment outcomes correlate well with eradication of the bacteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/28-31\">",
"     28-31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    LAP usually is detected in early adolescence. However, retrospective examination of earlier radiographs sometimes reveals undetected disease in the primary dentition, suggesting that LAP and localized prepubertal periodontitis may be the same entity. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Localized prepubertal'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Inflammation and accumulation of plaque in children with LAP occur to a greater extent than they do in the average teenager. In contrast, the inflammation in LAP is not as extreme as that seen in the forms of periodontitis associated with systemic disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/60/8137?source=see_link\">",
"     \"Systemic conditions associated with periodontal disease in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment of LAP consists of local debridement combined with systemic antibiotic therapy and microbiologic monitoring. Oral",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?27/38/28262?source=see_link\">",
"     tetracycline",
"    </a>",
"    has been used with some success, but",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?20/59/21425?source=see_link\">",
"     metronidazole",
"    </a>",
"    alone or in combination with",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/49/34583?source=see_link\">",
"     amoxicillin",
"    </a>",
"    appears to be more effective in arresting progression of the disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/20,32\">",
"     20,32",
"    </a>",
"    ].",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?34/15/35056?source=see_link\">",
"     Azithromycin",
"    </a>",
"    also has been shown to be effective and offers the advantage of a shorter three-day course of treatment and once-a-day dosing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/33\">",
"     33",
"    </a>",
"    ]. Reattachment and resolution of the periodontal defects may occur after antibiotic therapy. However, periodontal surgery often is necessary to repair the residual defects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Localized prepubertal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Localized prepubertal periodontitis (LPP) is a form of aggressive periodontitis that occurs in the primary dentition of children in the absence of systemic disease. In the United States, LPP occurs most commonly in the African-American population. An autosomal dominant pattern of inheritance has been described in one extended family [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    LPP is characterized by bilateral, symmetric, localized loss of attachment in the primary dentition, typically involving the molar area [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/21\">",
"     21",
"    </a>",
"    ]. LPP typically is accompanied by greater-than-average plaque deposits, calculus, and mild to moderate inflammation.",
"   </p>",
"   <p>",
"    LPP usually is diagnosed in the late primary or early transitional dentition. It may progress to LAP in the permanent dentition. LPP and LAP probably are the same disease, differing only in age of onset or detection. The distinctive tooth patterns probably are determined by sequence of tooth eruption and time of onset of disease. LPP has not been as extensively studied as LAP. However, LPP is thought to be the result of bacterial infection combined with specific, albeit minor, host immunologic deficits, including functional abnormalities of neutrophils or monocytes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/35\">",
"     35",
"    </a>",
"    ]. A causative bacterial species has not been identified, although there is some evidence that black-pigmented",
"    <em>",
"     Bacteroides",
"    </em>",
"    species may play a role [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Localized aggressive'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Treatment involves local debridement and antibiotic therapy. Based upon studies of the efficacy of LAP treatment,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?34/15/35056?source=see_link\">",
"     azithromycin",
"    </a>",
"    may be the antibiotic agent of choice in the treatment of LPP. Tetracyclines are contraindicated in the management of LPP because of the potential for staining the permanent teeth.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Generalized aggressive",
"    </span>",
"    &nbsp;&mdash;&nbsp;Generalized aggressive periodontitis (GAP), formerly called generalized juvenile periodontitis and rapidly progressive periodontitis, afflicts adolescents and younger adults (under 35 years of age). GAP affects the entire dentition; heavy accumulations of plaque and calculus are present. Inflammation may be severe, and bone loss is rapid. In contrast to LAP, GAP is not associated with A. actinomycetemcomitans, but has a microbiologic profile similar to that of chronic periodontitis. Smoking is a risk factor for GAP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32471/abstract/37\">",
"     37",
"    </a>",
"    ]. GAP must be treated aggressively with local periodontal therapy and systemic antibiotics, because it is not self-limiting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H995947623\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pediatric healthcare providers should be alert for signs of periodontal disease in children and adolescents. Signs of periodontitis that are apparent on visual inspection include heavy plaque (",
"      <a class=\"graphic graphic_picture graphicRef66029 \" href=\"mobipreview.htm?11/24/11651\">",
"       picture 1",
"      </a>",
"      ); calculus deposits (",
"      <a class=\"graphic graphic_picture graphicRef50438 \" href=\"mobipreview.htm?24/46/25313\">",
"       picture 2",
"      </a>",
"      ); enlargement or edema of the gingival tissues; redness, bleeding, or recession of the gingiva (",
"      <a class=\"graphic graphic_picture graphicRef70283 \" href=\"mobipreview.htm?23/40/24192\">",
"       picture 4",
"      </a>",
"      ); abnormal change in tooth position; and premature tooth mobility or tooth loss. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Periodontal examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Simple gingivitis is the most common periodontal problem in childhood, and inadequate oral hygiene is the most common cause. Predisposing factors may include orthodontic appliances (",
"      <a class=\"graphic graphic_picture graphicRef66029 \" href=\"mobipreview.htm?11/24/11651\">",
"       picture 1",
"      </a>",
"      ), dental crowding, chronic mouth breathing, and hormonal changes. The predominant clinical manifestations are edema and erythema (",
"      <a class=\"graphic graphic_picture graphicRef70283 \" href=\"mobipreview.htm?23/40/24192\">",
"       picture 4",
"      </a>",
"      ). In severe cases, the gingival tissues may bleed spontaneously. Childhood gingivitis is treated through improved oral hygiene. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Gingivitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute necrotizing ulcerative gingivitis is a painful gingivitis with rapid onset, interproximal and marginal soft tissue necrosis, ulceration, and bleeding. Predisposing factors include smoking, malnutrition, viral infections, stress, and sleep deprivation. Treatment involves local debridement, which usually produces rapid resolution. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Acute necrotizing ulcerative gingivitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Periodontitis is characterized by gingival inflammation with accompanying (and irreversible) loss of supportive connective tissues, including alveolar bone (",
"      <a class=\"graphic graphic_figure graphicRef67237 \" href=\"mobipreview.htm?21/27/21939\">",
"       figure 1",
"      </a>",
"      ). It results in apical migration of the attachment of the epithelium to the tooth surface and the development of a \"periodontal pocket.\" Chronic periodontitis may have its incipient onset in young patients, although it does not advance to significant disease until adulthood. Localized aggressive periodontitis, although rare, occurs in adolescents and prepubertal children and involves rapid destruction of the periodontal tissues. Periodontitis is precipitated by bacteria residing in biofilms in the gingival sulcus. Therapy consists of local debridement and systemic antibiotic therapy. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Periodontitis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/1\">",
"      Oliver RC, Brown LJ, Loe H. Variations in the prevalence and extent of periodontitis. J Am Dent Assoc 1991; 122:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/2\">",
"      Position paper: epidemiology of periodontal diseases. American Academy of Periodontology. J Periodontol 1996; 67:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/3\">",
"      Grossi SG, Genco RJ, Machtei EE, et al. Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. J Periodontol 1995; 66:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/4\">",
"      Genco RJ. Current view of risk factors for periodontal diseases. J Periodontol 1996; 67:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/5\">",
"      Thomson WM, Poulton R, Broadbent JM, et al. Cannabis smoking and periodontal disease among young adults. JAMA 2008; 299:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/6\">",
"      Hujoel PP. Destructive periodontal disease and tobacco and cannabis smoking. JAMA 2008; 299:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/7\">",
"      Torpy JM, Burke AE, Glass RM. JAMA patient page. Periodontal disease. JAMA 2008; 299:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/8\">",
"      Nakagawa S, Fujii H, Machida Y, Okuda K. A longitudinal study from prepuberty to puberty of gingivitis. Correlation between the occurrence of Prevotella intermedia and sex hormones. J Clin Periodontol 1994; 21:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/9\">",
"      Gusberti FA, Mombelli A, Lang NP, Minder CE. Changes in subgingival microbiota during puberty. A 4-year longitudinal study. J Clin Periodontol 1990; 17:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/10\">",
"      Oliver RC, Brown LJ, L&ouml;e H. Periodontal diseases in the United States population. J Periodontol 1998; 69:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/11\">",
"      Brown LJ, Oliver RC, L&ouml;e H. Periodontal diseases in the U.S. in 1981: prevalence, severity, extent, and role in tooth mortality. J Periodontol 1989; 60:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/12\">",
"      Matsson L. Factors influencing the susceptibility to gingivitis during childhood--a review. Int J Paediatr Dent 1993; 3:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/13\">",
"      Paster BJ, Boches SK, Galvin JL, et al. Bacterial diversity in human subgingival plaque. J Bacteriol 2001; 183:3770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/14\">",
"      Lamell CW, Griffen AL, McClellan DL, Leys EJ. Acquisition and colonization stability of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in children. J Clin Microbiol 2000; 38:1196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/15\">",
"      Tanner AC, Milgrom PM, Kent R Jr, et al. The microbiota of young children from tooth and tongue samples. J Dent Res 2002; 81:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/16\">",
"      Bhat M. Periodontal health of 14-17-year-old US schoolchildren. J Public Health Dent 1991; 51:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/17\">",
"      Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999; 4:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/18\">",
"      Watanabe K. Prepubertal periodontitis: a review of diagnostic criteria, pathogenesis, and differential diagnosis. J Periodontal Res 1990; 25:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/19\">",
"      Wara-aswapati N, Howell TH, Needleman HL, Karimbux N. Periodontitis in the child and adolescent. ASDC J Dent Child 1999; 66:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/20\">",
"      Seymour RA, Heasman PA. Pharmacological control of periodontal disease. II. Antimicrobial agents. J Dent 1995; 23:5.",
"     </a>",
"    </li>",
"    <li>",
"     Carranza FA. Prepubertal and juvenile periodontitis. In: Clinical Peridontology, WB Saunders, Philadelphia 1996. p.336.",
"    </li>",
"    <li>",
"     Aggressive periodontitis. In: Online Mendelian Inheritance in Man. Johns Hopkins University. file://omim.org/entry/170650 (Accessed on November 02, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/23\">",
"      Boughman JA, Halloran SL, Roulston D, et al. An autosomal-dominant form of juvenile periodontitis: its localization to chromosome 4 and linkage to dentinogenesis imperfecta and Gc. J Craniofac Genet Dev Biol 1986; 6:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/24\">",
"      Perez HD, Kelly E, Elfman F, et al. Defective polymorphonuclear leukocyte formyl peptide receptor(s) in juvenile periodontitis. J Clin Invest 1991; 87:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/25\">",
"      Page RC, Beatty P, Waldrop TC. Molecular basis for the functional abnormality in neutrophils from patients with generalized prepubertal periodontitis. J Periodontal Res 1987; 22:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/26\">",
"      Van Dyke TE, Levine MJ, Tabak LA, Genco RJ. Reduced chemotactic peptide binding in juvenile periodontitis: a model for neutrophil function. Biochem Biophys Res Commun 1981; 100:1278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/27\">",
"      Bowen TJ, Ochs HD, Altman LC, et al. Severe recurrent bacterial infections associated with defective adherence and chemotaxis in two patients with neutrophils deficient in a cell-associated glycoprotein. J Pediatr 1982; 101:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/28\">",
"      Tinoco EM, Beldi MI, Campedelli F, et al. Clinical and microbiological effects of adjunctive antibiotics in treatment of localized juvenile periodontitis. A controlled clinical trial. J Periodontol 1998; 69:1355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/29\">",
"      Christersson LA, Zambon JJ. Suppression of subgingival Actinobacillus actinomycetemcomitans in localized juvenile periodontitis by systemic tetracycline. J Clin Periodontol 1993; 20:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/30\">",
"      Haubek D, Ennibi OK, Poulsen K, et al. Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco: a prospective longitudinal cohort study. Lancet 2008; 371:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/31\">",
"      Shaddox LM, Huang H, Lin T, et al. Microbiological characterization in children with aggressive periodontitis. J Dent Res 2012; 91:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/32\">",
"      Sax&eacute;n L, Asikainen S. Metronidazole in the treatment of localized juvenile periodontitis. J Clin Periodontol 1993; 20:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/33\">",
"      Haas AN, de Castro GD, Moreno T, et al. Azithromycin as an adjunctive treatment of aggressive periodontitis: 12-months randomized clinical trial. J Clin Periodontol 2008; 35:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/34\">",
"      Shapira L, Schlesinger M, Bimstein E. Possible autosomal-dominant inheritance of prepubertal periodontitis in an extended kindred. J Clin Periodontol 1997; 24:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/35\">",
"      Delaney JE, Kornman KS. Microbiology of subgingival plaque from children with localized prepubertal periodontitis. Oral Microbiol Immunol 1987; 2:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/36\">",
"      Sweeney EA, Alcoforado GA, Nyman S, Slots J. Prevalence and microbiology of localized prepubertal periodontitis. Oral Microbiol Immunol 1987; 2:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32471/abstract/37\">",
"      Schenkein HA, Gunsolley JC, Koertge TE, et al. Smoking and its effects on early-onset periodontitis. J Am Dent Assoc 1995; 126:1107.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6280 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-3AAB480B33-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_45_32471=[""].join("\n");
var outline_f31_45_32471=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H995947623\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PERIODONTAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Normal findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      GINGIVITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Prevalence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Clinical findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      ACUTE NECROTIZING ULCERATIVE GINGIVITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      PERIODONTITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Epidemiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Aggressive periodontitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Localized aggressive",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Localized prepubertal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Generalized aggressive",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H995947623\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6280\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6280|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?21/27/21939\" title=\"figure 1\">",
"      Periodontal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6280|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?11/24/11651\" title=\"picture 1\">",
"      Mandibular gingivitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?24/46/25313\" title=\"picture 2\">",
"      Calculus deposits",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?30/51/31551\" title=\"picture 3\">",
"      Healthy gingiva child",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?23/40/24192\" title=\"picture 4\">",
"      Gingivitis child",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?31/49/32542\" title=\"picture 5\">",
"      Gingivitis mouth breather",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?27/6/27744\" title=\"picture 6\">",
"      Pregnancy gingivitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?6/34/6689\" title=\"picture 7\">",
"      Pubertal gingivitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?4/27/4532\" title=\"picture 8\">",
"      Inflammatory gingival overgrowth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6280|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?22/34/23084\" title=\"table 1\">",
"      Early primary tooth loss",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/33/18968?source=related_link\">",
"      Benefits and risks of smoking cessation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/21/18777?source=related_link\">",
"      Gingivitis and periodontitis in adults: Classification and dental treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/33/41497?source=related_link\">",
"      Management of smoking cessation in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/32/30216?source=related_link\">",
"      Soft tissue lesions of the oral cavity in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/60/8137?source=related_link\">",
"      Systemic conditions associated with periodontal disease in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_45_32472="Approach to the child with acute ataxia";
var content_f31_45_32472=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to the child with acute ataxia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/45/32472/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/45/32472/contributors\">",
"     Dewesh Agrawal, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/45/32472/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/45/32472/contributors\">",
"     Stephen J Teach, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/45/32472/contributors\">",
"     Marc C Patterson, MD, FRACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/45/32472/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/45/32472/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/45/32472/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ataxia can be defined as a disturbance in the smooth, accurate coordination of movements. It is most commonly manifested as an unsteady gait [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ataxia is usually the result of cerebellar dysfunction. However, disturbances at many levels of the nervous system can also affect coordination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/2\">",
"     2",
"    </a>",
"    ]. As an example, ataxia that develops as the result of loss of sensory function (such as proprioception) would be described as a sensory ataxia.",
"   </p>",
"   <p>",
"    Acute ataxia is an uncommon presenting complaint in children. Although causes of acute ataxia include life-threatening conditions such as mass lesions and central nervous system (CNS) infection, the majority of children have a benign, self-limited process. Historical features, specific physical findings, and selected ancillary studies can identify most causes of ataxia, particularly those that are serious and require stabilization and intervention.",
"   </p>",
"   <p>",
"    This topic will review causes and clinical features of acute ataxia in children. Episodic and chronic conditions associated with ataxia will be discussed briefly. An algorithmic approach to the child with acute ataxia is presented.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CAUSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conditions that cause acute ataxia include acute infections, post-infectious inflammatory conditions, toxins, tumors, and trauma (",
"    <a class=\"graphic graphic_table graphicRef79383 \" href=\"mobipreview.htm?28/9/28830\">",
"     table 1",
"    </a>",
"    ). In one retrospective series, 80 percent of children with acute ataxia who were evaluated in an emergency department and subsequently hospitalized had a discharge diagnosis of acute cerebellar ataxia, a toxic ingestion, or Guillain-Barr&eacute; syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Historical features such as the time course of the presentation and the age of the child may suggest a particular diagnosis. Conditions such as migraine syndromes, seizures, and certain inborn errors of metabolism cause recurrent ataxia. In comparison, chronic or progressive ataxia usually develops with congenital anomalies, degenerative diseases, or hereditary ataxias.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Life-threatening conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Life-threatening causes of acute ataxia in children are fortunately uncommon. For those conditions that create a mass effect, signs and symptoms of increased intracranial pressure (such as vomiting, headache, or papilledema) are typically evident. Etiologies include tumors, hemorrhage, stroke, and infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Of all childhood brain tumors, 45 to 60 percent arise in the brainstem or cerebellum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Posterior fossa tumors may present with slowly progressive ataxia and symptoms of increased intracranial pressure. These symptoms include progressive night-time or early morning headache with",
"    <span class=\"nowrap\">",
"     nausea/vomiting.",
"    </span>",
"    The absence of these symptoms, however, does not exclude the diagnosis of a brain tumor. Physical findings that may be noted with a posterior fossa tumor include papilledema, cranial neuropathies, and other focal neurologic abnormalities. Acute decompensation can occur as the result of obstructive hydrocephalus, hemorrhage into the lesion, or edema. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/0/2058?source=see_link&amp;anchor=H4#H4\">",
"     \"Epidemiology, treatment, and prognosis of medulloblastoma\", section on 'Signs and symptoms'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Acute ataxia in association with opsoclonus-myoclonus (rapid, dancing eye movements and rhythmic jerking) may be the presenting manifestation of an occult neuroblastoma. As many as half of children with opsoclonus-myoclonus-ataxia have a neuroblastoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/15/15609?source=see_link\">",
"     \"Clinical presentation, diagnosis, and staging evaluation of neuroblastoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Intracranial hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemorrhage into the cerebellum or posterior fossa as the result of trauma or a vascular malformation can cause ataxia with dramatic, rapid deterioration and life-threatening elevation of intracranial pressure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Injury that causes intraparenchymal hemorrhage is typically severe. In comparison, a child with a ruptured vascular malformation typically has no significant antecedent trauma. A history of trauma may not be immediately forthcoming for children with inflicted injury. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/13/32985?source=see_link\">",
"     \"Child abuse: Epidemiology, mechanisms, and types of abusive head trauma in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Stroke",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute ataxia may develop as the result of vertebral or basilar artery disease. Conditions that cause cerebrovascular disease are rare in children and include sickle cell disease, hypercoagulable states (as can occur with systemic lupus erythematous), and homocystinuria. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/11/31930?source=see_link\">",
"     \"Cerebrovascular complications of sickle cell disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/42/27303?source=see_link&amp;anchor=H11#H11\">",
"     \"Hematologic problems in children and adolescents with systemic lupus erythematosus\", section on 'Antiphospholipid antibodies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Vertebrobasilar artery dissection following a neck injury can also cause stroke, manifested as acute ataxia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Life-threatening infectious processes that cause acute ataxia (such as cerebellar abscesses) generally produce other symptoms as well. Rarely, ataxia may be an early symptom of meningitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/10\">",
"     10",
"    </a>",
"    ]. Patients with inflammatory post-infectious conditions, such as acute post-infectious demyelinating encephalomyelitis (ADEM), may also develop ataxia.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cerebellar abscesses, often caused by contiguous spread of infection from either otitis media or mastoiditis, can cause ataxia and fever [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/11,12\">",
"       11,12",
"      </a>",
"      ]. Associated symptoms related to a mass effect in the posterior fossa include headache and vomiting. Rapid clinical deterioration with meningismus can occur when the abscess ruptures into the intraventricular or subarachnoid space [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/13\">",
"       13",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/13/38104?source=see_link\">",
"       \"Pathogenesis, clinical manifestations, and diagnosis of brain abscess\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Brainstem encephalitis is a rare cause of acute ataxia that is associated with high morbidity. Patients are often febrile and have other neurologic findings such as cranial nerve abnormalities, mental status changes, and seizures [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/10\">",
"       10",
"      </a>",
"      ]. Cerebrospinal fluid (CSF) pleocytosis and electroencephalographic (EEG) changes are commonly seen. Infectious agents associated with brainstem inflammation include Listeria monocytogenes, Lyme disease, EBV, and herpes virus. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/44/1736?source=see_link&amp;anchor=H9#H9\">",
"       \"Clinical manifestations and diagnosis of Listeria monocytogenes infection\", section on 'Rhombencephalitis'",
"      </a>",
"      .) Reflexes are preserved in patients with encephalitis, which helps to differentiate them from those with Guillain-Barr&eacute; or Miller Fisher syndrome. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Common conditions'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      ADEM, an uncommon inflammatory demyelinating disease that typically follows an infection, may have ataxia as part of its presentation. Common neurologic features of ADEM include seizures, cranial neuropathies, weakness, hemiparesis, sensory deficits, and transverse myelitis. Systemic symptoms such as fever, headache, and meningismus may also occur. Altered mental status and the fulminant onset of multifocal neurologic deficits distinguish ADEM from benign etiologies such as acute cerebellar ataxia. Although most patients slowly recover and have no neurologic deficit, mortality from postinfectious ADEM may be as high as 5 percent. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/52/25416?source=see_link\">",
"       \"Acute disseminated encephalomyelitis in children: Pathogenesis, clinical features, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Common conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common conditions that cause acute ataxia in children are often treatable",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    self-limited.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Acute cerebellar ataxia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute cerebellar ataxia is the most common cause of childhood ataxia, accounting for about 30 to 50 percent of all cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/3,14,15\">",
"     3,14,15",
"    </a>",
"    ]. It is a self-limited syndrome that is frequently postinfectious and typically seen in children between two and five years of age. The diagnosis of acute cerebellar ataxia can only be made after exclusion of other more serious illnesses such as toxic ingestions, central nervous system infection, structural intracranial lesions, metabolic derangement, or neurodegenerative disorders. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/34/10790?source=see_link\">",
"     \"Acute cerebellar ataxia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Guillain-Barr&eacute; syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Guillain-Barr&eacute; syndrome (GBS) is an acute inflammatory demyelinating polyradiculoneuropathy thought to result from a post-infectious immune-mediated process. It has also been reported following vaccination. GBS predominantly affects motor nerves, although as many as 15 percent of children with GBS also lose sensory input to the cerebellum and develop sensory ataxia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/3/27705?source=see_link\">",
"     \"Overview of Guillain-Barr&eacute; syndrome in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The Miller Fisher syndrome is a form of GBS classically characterized by the triad of ataxia, areflexia, and ophthalmoplegia. Ataxia can be profound and is often more marked in the extremities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/2,16\">",
"     2,16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/3/27705?source=see_link&amp;anchor=H13#H13\">",
"     \"Overview of Guillain-Barr&eacute; syndrome in children\", section on 'Miller Fisher syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ataxia associated with GBS usually progresses over several days. The prognosis for children with GBS is generally better than that for adults. As many as 85 percent of children can be expected to have an excellent recovery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Labyrinthitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammation of the vestibular apparatus, often from bacterial or viral infections such as otitis media, causes acute labyrinthitis. Symptoms include hearing loss, vomiting, and intense vertigo exacerbated by head movements [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. Labyrinthitis may be difficult to distinguish from acute cerebellar ataxia in a toddler. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/15/35062?source=see_link&amp;anchor=H3#H3\">",
"     \"Vestibular neuritis\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Toxic exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Toxic exposure (typically ingestion of an oral medication) is responsible for up to 30 percent of cases of acute childhood ataxia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Associated symptoms may include mental status changes such as lethargy, confusion, or inappropriate speech or behavior. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/60/22474?source=see_link\">",
"     \"Approach to the child with occult toxic exposure\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Exposures commonly associated with ataxia include anticonvulsants (",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?32/19/33082?source=see_link\">",
"     phenytoin",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?5/36/5706?source=see_link\">",
"     carbamazepine",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?28/63/29689?source=see_link\">",
"     phenobarbital",
"    </a>",
"    , and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?41/11/42167?source=see_link\">",
"     primidone",
"    </a>",
"    ), lead, carbon monoxide, inhalants (such as toluene), alcohol, benzodiazepines, and other drugs of abuse. Some substances associated with abuse can be identified in routine urine toxicology screens. A few medications and toxins (such as anticonvulsants, ethanol, and lead) can be identified with specific blood tests.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Migraine syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute ataxia is a clinical feature of several migraine syndromes, including basilar migraines and familial hemiplegic migraines. Benign paroxysmal vertigo (BPV) can be difficult to distinguish from ataxia in young children. Children with BPV may have a family history of migraine, and some develop typical migraines later in life. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/21/42327?source=see_link\">",
"     \"Classification of migraine in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/31/29175?source=see_link&amp;anchor=H3#H3\">",
"     \"Nonepileptic paroxysmal disorders in children\", section on 'Benign paroxysmal vertigo'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Associated symptoms such as headache and vomiting, as well as the episodic course, distinguish migraine syndromes from other causes of acute ataxia. However, the diagnosis may be difficult to establish at the initial presentation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ataxia may occur following mild traumatic brain injury. Ataxia in association with post-traumatic vertigo is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/59/29626?source=see_link&amp;anchor=H20#H20\">",
"     \"Concussion and mild traumatic brain injury\", section on 'Post-traumatic vertigo'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Other conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of other conditions that can cause acute and chronic ataxia.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tick paralysis &ndash; Tick paralysis is a form of toxic exposure that may present with ataxia. Patients develop an unsteady gait that progresses to motor weakness, ascending paralysis, and areflexia. Fever, headache, and mental status changes are characteristically absent. A neurotoxin in the tick saliva causes the symptoms. The onset of symptoms of tick paralysis occurs only after a female tick has attached and begun feeding. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/26/3494?source=see_link\">",
"       \"Tick paralysis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hypoglycemia &mdash; Younger children with hypoglycemia may appear ataxic [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/3,10\">",
"       3,10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Seizure disorder &ndash; Ataxia can occur during the ictal or postictal phases of seizures [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/2,10\">",
"       2,10",
"      </a>",
"      ]. Other epileptic features (such as mental status change or abnormal eye movements) may be noted. However, nonconvulsive seizures (without alterations of consciousness or abnormal movements) may manifest as ataxia alone [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Conversion disorder &ndash; A conversion disorder (functional ataxia) may be the cause of ataxia for a patient with physical findings that are physiologically inconsistent, such as a narrow-based gait and elaborate \"near falls.\" The clinician must take a thorough history and perform a careful physical examination to exclude other causes before concluding that the cause of patient's symptoms is functional. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/20/5450?source=see_link&amp;anchor=H19#H19\">",
"       \"Somatization: Epidemiology, pathogenesis, clinical features, medical evaluation, and diagnosis\", section on 'Classification in DSM-IV-TR'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Inborn errors of metabolism &ndash; Numerous inborn errors of metabolism affecting the central and peripheral nervous system may lead to episodic presentations of acute ataxia. A child with one of these yet undiagnosed metabolic disorders may present acutely with the first episode of ataxia and metabolic decompensation in the setting of an intercurrent illness and poor dietary intake. Specific disorders include urea cycle disorders, amino acidopathies, mitochondrial disorders, and organic acidopathies. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/58/24489?source=see_link&amp;anchor=H4#H4\">",
"       \"Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features\", section on 'Clinical manifestations'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/35/37433?source=see_link\">",
"       \"Overview of the hereditary ataxias\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Congenital anomalies &ndash; Congenital anomalies of the posterior fossa are sometimes associated with ataxia. Observers may not recognize coordination difficulties until maturational motor milestones are delayed, at which point the child may present for acute evaluation. Congenital anomalies of the posterior fossa include Dandy-Walker syndrome, Chiari malformation, encephaloceles, agenesis of the cerebellar vermis and cerebellar aplasia, dysplasia, or hypoplasia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Degenerative/genetic",
"      </span>",
"      conditions &ndash; Degenerative",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      genetic conditions associated with chronic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      progressive ataxia include ataxia-telangiectasia, spinocerebellar ataxia, Pelizaeus-Merzbacher disease, neuronal ceroid lipofuscinosis, Niemann-Pick disease, sialidosis, Friedreich ataxia, abetalipoproteinemia, vitamin E deficiency, GM2 gangliosidosis, Refsum disease, dyssynergia cerebellaris myoclonica (previously, Ramsay Hunt syndrome type I), and multiple sclerosis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/35/37433?source=see_link\">",
"       \"Overview of the hereditary ataxias\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/32/12809?source=see_link\">",
"       \"Pathogenesis, clinical features, and diagnosis of pediatric multiple sclerosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most children with ataxia present with refusal to walk or with a wide-based, \"drunken\" gait. Specific features of the history that may help to identify the underlying cause of the ataxia include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Onset of symptoms &ndash; A rapid onset is typically indicative of a traumatic, infectious, post-infectious, or toxic etiology. Guillain-Barr&eacute; syndrome (GBS) and metabolic syndromes usually present with a slower, more progressive onset of symptoms, usually over a few days. A slower and relatively insidious course is characteristic of brainstem and cerebellar tumors, although medulloblastomas may grow rapidly, and acute decompensation may occur secondary to obstructive hydrocephalus or hemorrhage into the lesion.",
"     </li>",
"     <li>",
"      Associated symptoms",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Otalgia, vertigo, and vomiting in association with acute ataxia suggest acute labyrinthitis. An older child with inner ear disease may complain of dizziness. Most children also have nystagmus.",
"     </li>",
"     <li>",
"      Recurrent night-time or early-morning headaches with or without vomiting are symptoms of increased intracranial pressure that may develop with a brain tumor. The absence of these symptoms, however, does not exclude the diagnosis. Personality and behavioral changes may also signal the presence of increased intracranial pressure with hydrocephalus.",
"     </li>",
"     <li>",
"      Abnormal mental status is a worrisome symptom that can develop in many conditions that cause acute ataxia, including mass lesions, central nervous system (CNS) infection, toxic exposure, trauma, stroke, and inborn errors of metabolism.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Access to medications (prescription medications, anticonvulsants, over-the-counter drugs, drugs of abuse, and ethanol), and other toxic substances should be determined.",
"     </li>",
"     <li>",
"      A history of antecedent head trauma is consistent with an intracranial injury, whereas neck trauma suggests a stroke as the result of a vascular injury to the vertebral or basilar artery.",
"     </li>",
"     <li>",
"      Patients with a recent infection or vaccination may have a post-infectious demyelinating process such as acute cerebellar ataxia, GBS, or acute post-infectious demyelinating encephalomyelitis (ADEM).",
"     </li>",
"     <li>",
"      Previous similar episodes of acute ataxia suggest an episodic disorder such as a migraine syndrome, seizure, or inborn error of metabolism.",
"     </li>",
"     <li>",
"      Children with family members with ataxia may have migraine syndromes, hereditary ataxias, or inborn errors of metabolism.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;A systematic, yet flexible, approach to the physical examination is necessary to localize the source of the child's symptoms. For young children who may be anxious or uncomfortable, careful observation of the patient's movements and social interactions with the caregiver may provide more information than some parts of the formal examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     General examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormal vital signs must be recognized immediately. As an example, bradycardia, abnormal respiratory pattern, and hypertension may occur with increased intracranial pressure. The presence of fever is consistent with an infectious process. Other pertinent features of the general examination include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bulging of the anterior fontanel may indicate increased intracranial pressure with a life-threatening cause of ataxia. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Life-threatening conditions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An ipsilateral head tilt may be associated with posterior fossa tumors.",
"     </li>",
"     <li>",
"      For the child who tolerates a funduscopic examination, papilledema indicates increased intracranial pressure as may occur in posterior fossa tumors that obstruct spinal fluid flow leading to hydrocephalus.",
"     </li>",
"     <li>",
"      Nystagmus can develop with vestibular, cerebellar, or brainstem disorders. Opsoclonus may be associated with an occult neuroblastoma.",
"     </li>",
"     <li>",
"      Otitis media and hearing loss in association with vomiting and intense vertigo indicate acute labyrinthitis.",
"     </li>",
"     <li>",
"      Meningismus with fever and a toxic appearance is concerning for a CNS infection.",
"     </li>",
"     <li>",
"      A healing rash or viral exanthem may be a clue to the infectious antecedent in acute post-infectious cerebellar ataxia. Tick paralysis may be the cause of ataxia when an attached tick is noted.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Neurologic examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The neurologic examination includes specific examination techniques as well as observations made while taking the history and throughout the general physical examination. The approach to the neurologic examination of a child is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/17/14618?source=see_link&amp;anchor=H10928992#H10928992\">",
"     \"Detailed neurologic assessment of infants and children\", section on 'Neurologic examination'",
"    </a>",
"    .) Features that are associated with various causes of acute ataxia include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mental status &ndash; Abnormal mental status suggests ingestion, ADEM, meningitis, encephalitis, or stroke. Lethargy may be present in many inborn errors of metabolism. In comparison, children with post-infectious acute cerebellar ataxia are normally alert and interactive.",
"     </li>",
"     <li>",
"      Cranial nerves &ndash; Abnormalities of cranial nerve function suggest posterior fossa lesions, brainstem encephalitis, or the Miller Fisher syndrome.",
"     </li>",
"     <li>",
"      Motor examination &ndash; Children with the acute onset of weakness may stagger as an attempt to compensate. This gait abnormality may be mistaken for true ataxia and has been called \"paretic\" ataxia. Paretic ataxia is proportional to the degree of weakness. It may be due to GBS, botulism, myasthenia gravis, transverse myelitis, or tick paralysis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/10\">",
"       10",
"      </a>",
"      ]. Deep tendon reflexes are absent in patients with GBS, botulism, and tick paralysis.",
"     </li>",
"     <li>",
"      Sensory examination &ndash; Impairment of proprioceptive input may result in sensory ataxia, as may occur with GBS. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Guillain-Barr&eacute; syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cerebellar examination &ndash; A cerebellar lesion is the likely cause of ataxia for a patient with an abnormal cerebellar examination. However, patients with significant cerebellar dysfunction may have no specific findings. Cerebellar signs include abnormalities in gait, speech, and coordination of voluntary movement. Gait is typically wide-based, unsteady, lurching, or staggering. Speech abnormalities include fluctuations in clarity, rhythm, tone, and volume. Patients may have difficulty maintaining truncal position (titubation). Coordination of voluntary movement, as demonstrated with over- or under-shooting (best seen on finger-nose testing) and difficulty with rapid alternating movements (dysdiadochokinesia), is poor. Hypotonia and tremor may also occur.",
"      <br/>",
"      <br/>",
"      Findings that localize the disorder within the cerebellum include the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Vermis (midline cerebellar) lesions cause dysarthria, truncal titubation and gait abnormalities.",
"     </li>",
"     <li>",
"      Lesions of the cerebellar hemispheres result in ipsilateral limb dysmetria, hypotonia, and tremor. Children may veer in the direction of the affected cerebellar hemisphere when walking.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Ancillary studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ancillary studies, as indicated by a thorough history and physical examination, may identify serious",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    treatable causes of acute ataxia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Laboratory",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Toxicologic screen &ndash; A urine screen for drugs of abuse or blood for specific drug levels (as suggested by the history) may be the most useful diagnostic test for children with acute ataxia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/2\">",
"       2",
"      </a>",
"      ]. In a retrospective review of 40 cases of acute childhood ataxia evaluated in the emergency department at one institution, nearly half of the 35 drug screens sent were positive [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Blood glucose &ndash; A bedside test for blood glucose will quickly identify children with hypoglycemia.",
"     </li>",
"     <li>",
"      Metabolic evaluation &ndash; For children with episodic acute ataxia and other features that suggest an inborn error of metabolism (such as altered mental status or family history), the following tests may be useful: liver function tests, blood pH, CBC, quantitative amino acid determinations of blood and urine, serum lactate, pyruvate and ammonia levels, and urine organic acids.",
"     </li>",
"     <li>",
"      Cerebrospinal fluid (CSF) examination &ndash; CSF should be obtained whenever there is concern for CNS infection, such as meningitis or encephalitis. Otherwise, CSF examination is rarely indicated for the emergent evaluation of a child with acute ataxia. Moderate CSF protein elevation can occur in acute cerebellar ataxia, ADEM, and multiple sclerosis. CSF protein is also usually elevated in GBS, but it may be normal in as many as 20 percent of children within a week of symptom onset [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/2\">",
"       2",
"      </a>",
"      ]. Neuroimaging should be obtained before a lumbar puncture is performed when there is concern for increased intracranial pressure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuroimaging should be obtained for patients with acute ataxia who have altered levels of consciousness, focal neurologic signs, cranial neuropathies, marked asymmetry of ataxia, concern for a mass lesion, or a history of trauma. Imaging may also be helpful when considering a diagnosis of exclusion, such as acute cerebellar ataxia or a conversion disorder.",
"   </p>",
"   <p>",
"    Magnetic resonance imaging (MRI) is the imaging modality of choice for patients with acute ataxia, although MRI may be difficult to obtain emergently. It is superior to computed tomography (CT) for detection of posterior fossa lesions such as tumors, strokes, and abscesses. In addition, patients with demyelinating diseases or brainstem encephalitis may have abnormalities detected with MRI.",
"   </p>",
"   <p>",
"    CT is generally more available emergently than MRI. CT can usually detect conditions that require immediate surgical intervention such as hydrocephalus, traumatic injury, and many mass lesions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Electrophysiologic studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrophysiologic studies are rarely necessary for the evaluation of acute ataxia. In consultation with a pediatric neurologist, EEG is indicated for children who may be having seizures, as suggested by altered levels of consciousness",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fluctuating clinical signs. EEG may also demonstrate nonspecific abnormalities that are clues to a metabolic etiology or toxic exposure. Although electrophysiologic studies are the most specific and sensitive tests for diagnosis of Guillain-Barr&eacute; syndrome, they may not be helpful early in the disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/3/27705?source=see_link&amp;anchor=H15#H15\">",
"     \"Overview of Guillain-Barr&eacute; syndrome in children\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     ALGORITHMIC APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with acute ataxia have a disturbance in the smooth, accurate coordination of movements that is most commonly manifested as an unsteady gait. Although many causes of acute ataxia are benign, patients with life-threatening processes must be quickly identified (",
"    <a class=\"graphic graphic_table graphicRef79383 \" href=\"mobipreview.htm?28/9/28830\">",
"     table 1",
"    </a>",
"    ). Clinical manifestations and selected ancillary testing can identify conditions requiring stabilization and intervention (such as increased intracranial pressure from a tumor or intracranial hemorrhage) (",
"    <a class=\"graphic graphic_algorithm graphicRef77260 \" href=\"mobipreview.htm?38/11/39090\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Historical features typically distinguish episodic and chronic conditions that cause ataxia from those that are acute (with the exception of the initial presentation of an episodic condition).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Episodic conditions &ndash; Migraine syndromes such as basilar migraines usually have clinical features such as headache and vomiting. There may be a family history of migraine. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/21/42327?source=see_link\">",
"       \"Classification of migraine in children\"",
"      </a>",
"      .) The recurrence of ataxia with altered awareness suggests the diagnosis of a nonconvulsive seizure disorder, although some patients may have neither altered awareness nor abnormal movements. Patients with inborn errors of metabolism typically have other symptoms such as altered mental status. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/58/24489?source=see_link&amp;anchor=H4#H4\">",
"       \"Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features\", section on 'Clinical manifestations'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/35/37433?source=see_link\">",
"       \"Overview of the hereditary ataxias\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Chronic conditions &ndash; For children with chronic conditions (such as congenital anomalies and degenerative neurologic conditions), ataxia is typically chronic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      progressive, rather than acute. A sudden change in symptoms, however, may be the result of an acute condition. As an example, a child with chronic ataxia taking anticonvulsants who becomes acutely worse may have a toxic drug level. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/35/37433?source=see_link\">",
"       \"Overview of the hereditary ataxias\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/44/32458?source=see_link\">",
"       \"Epidemiology and clinical features of multiple sclerosis in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with the acute onset of ataxia following head or neck trauma require emergent head CT to diagnose conditions such as intracranial hemorrhage, cerebellar contusion, or a stroke (as the result of vascular injury). Although a negative CT scan is reassuring, patients with neck trauma may require further evaluation to identify a vertebrobasilar artery dissection. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Life-threatening conditions'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Patients with head injury and a normal CT scan likely have a post-concussive syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/59/29626?source=see_link&amp;anchor=H20#H20\">",
"     \"Concussion and mild traumatic brain injury\", section on 'Post-traumatic vertigo'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     No trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients with acute ataxia without a history of trauma, those with life-threatening conditions often have worrisome signs or symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Life-threatening signs/symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with evidence of increased intracranial pressure (papilledema, headache,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    vomiting), focal neurologic examination, or fever with meningismus should receive emergent head CT. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Life-threatening conditions'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Abnormal CT &ndash; Conditions that may be diagnosed on CT include posterior fossa tumor, hydrocephalus, cerebellar abscess, increased intracranial pressure with tonsillar herniation, and stroke.",
"     </li>",
"     <li>",
"      Normal CT &ndash; The CT scan is typically normal for patients with meningitis, brainstem encephalitis, or ADEM. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/52/25416?source=see_link\">",
"       \"Acute disseminated encephalomyelitis in children: Pathogenesis, clinical features, and diagnosis\"",
"      </a>",
"      .) A lumbar puncture should be considered to obtain CSF for analysis and culture.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     No life-threatening signs/symptoms",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Toxic exposure &ndash; Toxic exposures include accidental ingestions, recreational ingestions, or toxic levels of a prescribed medication. Appropriate subsequent management includes supportive care, administering an antidote (when one is available), or adjusting the medication dose. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/60/22474?source=see_link\">",
"       \"Approach to the child with occult toxic exposure\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Weakness, areflexia &ndash; Children with acute ataxia, weakness, and areflexia are likely to have GBS or Miller Fisher syndrome. Further diagnostic evaluation may include electrophysiologic studies. Treatment focuses on supportive care, although some patients may receive immunoglobulin therapy or plasma exchange. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/51/41781?source=see_link\">",
"       \"Treatment of Guillain-Barr&eacute; syndrome in children\"",
"      </a>",
"      .) Tick paralysis also presents with ataxia in conjunction with motor weakness and areflexia. The presence of an attached tick and improvement in symptoms after tick removal clinches this diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/26/3494?source=see_link\">",
"       \"Tick paralysis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Opsoclonus-myoclonus &ndash; Neuroblastoma is common among children with opsoclonus-myoclonus (although the percentage of children with neuroblastoma who have this paraneoplastic syndrome is small). Consequently, children with opsoclonus-myoclonus-ataxia should receive an aggressive oncologic evaluation. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/15/15609?source=see_link\">",
"       \"Clinical presentation, diagnosis, and staging evaluation of neuroblastoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Acute otitis",
"      <span class=\"nowrap\">",
"       media/vertigo",
"      </span>",
"      &ndash; Inflammation of the vestibular apparatus (with or without infection) may cause vertigo. Vertigo may be difficult to distinguish from ataxia in young children. Suppurative otitis media that causes labyrinthitis may require myringotomy, in addition to antibiotic therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Recent viral illness &ndash; Post-infectious acute cerebellar ataxia is one of the most common causes of acute ataxia in children [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32472/abstract/2,3,10\">",
"       2,3,10",
"      </a>",
"      ]. Patients are typically afebrile, with normal mental status. A careful history and physical examination may exclude many other causes of acute ataxia. To establish the diagnosis of acute cerebellar ataxia, a urine toxicologic screen, examination of CSF (to exclude meningitis or encephalitis)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      imaging (to exclude a significant intracranial process) may be considered, particularly for children who are irritable or have an equivocal neurologic examination. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Acute cerebellar ataxia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Conversion disorder &ndash; Conversion disorder is a diagnosis of exclusion. Patients typically have physical findings that are physiologically inconsistent, such as a narrow-based gait and elaborate \"near falls.\" Evaluation for this condition should include a urine toxicologic screen and, for post-menarchal girls, a urine pregnancy test. Some patients may require imaging to be certain that there is no significant intracranial lesion associated with the symptoms. A psychosocial evaluation or referral should be considered.(See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/20/5450?source=see_link&amp;anchor=H19#H19\">",
"       \"Somatization: Epidemiology, pathogenesis, clinical features, medical evaluation, and diagnosis\", section on 'Classification in DSM-IV-TR'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/37/30289?source=see_link\">",
"       \"Patient information: Acute cerebellar ataxia (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute ataxia is disturbance in the coordination of movement. In children it is most commonly manifested as an unsteady gait. Although many causes of acute ataxia are benign, patients with life-threatening processes must be quickly identified (",
"    <a class=\"graphic graphic_table graphicRef79383 \" href=\"mobipreview.htm?28/9/28830\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Causes'",
"    </a>",
"    above.) The cause of ataxia can usually be identified with careful history and physical examination and selected ancillary testing. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Evaluation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    An algorithmic approach to the child with acute ataxia is recommended (",
"    <a class=\"graphic graphic_algorithm graphicRef77260 \" href=\"mobipreview.htm?38/11/39090\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H25\">",
"     'Algorithmic approach'",
"    </a>",
"    above.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Friday JH. Ataxia. In: Textbook of Pediatric Medicine, 6th, Fleisher GR, Ludwig SL.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2010. p.164.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32472/abstract/2\">",
"      Ryan MM, Engle EC. Acute ataxia in childhood. J Child Neurol 2003; 18:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32472/abstract/3\">",
"      Gieron-Korthals MA, Westberry KR, Emmanuel PJ. Acute childhood ataxia: 10-year experience. J Child Neurol 1994; 9:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32472/abstract/4\">",
"      Pollack IF. Brain tumors in children. N Engl J Med 1994; 331:1500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32472/abstract/5\">",
"      Ullrich NJ, Pomeroy SL. Pediatric brain tumors. Neurol Clin 2003; 21:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32472/abstract/6\">",
"      Matthay KK, Blaes F, Hero B, et al. Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004. Cancer Lett 2005; 228:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32472/abstract/7\">",
"      Tate ED, Allison TJ, Pranzatelli MR, Verhulst SJ. Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome. J Pediatr Oncol Nurs 2005; 22:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32472/abstract/8\">",
"      Aryan HE, Giannotta SL, Fukushima T, et al. Aneurysms in children: review of 15 years experience. J Clin Neurosci 2006; 13:188.",
"     </a>",
"    </li>",
"    <li>",
"     Greenes DS. Neurotrauma. In: Textbook of Pediatric Emergency Medicine, 6th, Fleisher GR, Ludwig SL.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2010. p.1422.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32472/abstract/10\">",
"      Stumpf DA. Acute ataxia. Pediatr Rev 1987; 8:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32472/abstract/11\">",
"      Fischer EG, McLennan JE, Suzuki Y. Cerebral abscess in children. Am J Dis Child 1981; 135:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32472/abstract/12\">",
"      Hegde AS, Venkataramana NK, Das BS. Brain abscess in children. Childs Nerv Syst 1986; 2:90.",
"     </a>",
"    </li>",
"    <li>",
"     Townsend GC. Brain abscess and other focal pyogenic infections. In: Infectious Diseases, 2nd, Cohen J, Powderly WG.  (Eds), Mosby, Edinburgh 2004. p.279.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32472/abstract/14\">",
"      Salas AA, Nava A. Acute cerebellar ataxia in childhood: initial approach in the emergency department. Emerg Med J 2010; 27:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32472/abstract/15\">",
"      Nussinovitch M, Prais D, Volovitz B, et al. Post-infectious acute cerebellar ataxia in children. Clin Pediatr (Phila) 2003; 42:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32472/abstract/16\">",
"      Mori M, Kuwabara S, Fukutake T, et al. Clinical features and prognosis of Miller Fisher syndrome. Neurology 2001; 56:1104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32472/abstract/17\">",
"      Casselbrant ML, Mandel EM. Balance disorders in children. Neurol Clin 2005; 23:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32472/abstract/18\">",
"      Tusa RJ. Bedside assessment of the dizzy patient. Neurol Clin 2005; 23:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32472/abstract/19\">",
"      Pellegrini S, Gonzalez Macchi ME, Sommerfleck PA, Bern&aacute;ldez PC. Intratemporal complications from acute otitis media in children: 17 cases in two years. Acta Otorrinolaringol Esp 2012; 63:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32472/abstract/20\">",
"      Bennett HS, Selman JE, Rapin I, Rose A. Nonconvulsive epileptiform activity appearing as ataxia. Am J Dis Child 1982; 136:30.",
"     </a>",
"    </li>",
"    <li>",
"     Augustine EF, Johnston MV. Movement disorders. In: Nelson Textbook of Pediatrics, 19th, Kliegman RM, Stanton BF, St.Geme, et al.  (Eds), Saunders, Philadelphia 2011. p.2053.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32472/abstract/22\">",
"      Miyamoto RC, Miyamoto RT. Pediatric neurotology. Semin Pediatr Neurol 2003; 10:298.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6465 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-217.117.136.88-29CCF0041E-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_45_32472=[""].join("\n");
var outline_f31_45_32472=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CAUSES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Life-threatening conditions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Tumors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Intracranial hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Stroke",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Common conditions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Acute cerebellar ataxia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Guillain-Barr&eacute; syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Labyrinthitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Toxic exposure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Migraine syndromes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Trauma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Other conditions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - General examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Neurologic examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Ancillary studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Laboratory",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Electrophysiologic studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      ALGORITHMIC APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Trauma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      No trauma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Life-threatening signs/symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - No life-threatening signs/symptoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6465\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6465|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?38/11/39090\" title=\"algorithm 1\">",
"      Acute ataxia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6465|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/9/28830\" title=\"table 1\">",
"      Etiology of ataxia by age",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/34/10790?source=related_link\">",
"      Acute cerebellar ataxia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/52/25416?source=related_link\">",
"      Acute disseminated encephalomyelitis in children: Pathogenesis, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/60/22474?source=related_link\">",
"      Approach to the child with occult toxic exposure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/11/31930?source=related_link\">",
"      Cerebrovascular complications of sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/13/32985?source=related_link\">",
"      Child abuse: Epidemiology, mechanisms, and types of abusive head trauma in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/21/42327?source=related_link\">",
"      Classification of migraine in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/44/1736?source=related_link\">",
"      Clinical manifestations and diagnosis of Listeria monocytogenes infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/15/15609?source=related_link\">",
"      Clinical presentation, diagnosis, and staging evaluation of neuroblastoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/59/29626?source=related_link\">",
"      Concussion and mild traumatic brain injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/17/14618?source=related_link\">",
"      Detailed neurologic assessment of infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/44/32458?source=related_link\">",
"      Epidemiology and clinical features of multiple sclerosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/0/2058?source=related_link\">",
"      Epidemiology, treatment, and prognosis of medulloblastoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/42/27303?source=related_link\">",
"      Hematologic problems in children and adolescents with systemic lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/58/24489?source=related_link\">",
"      Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/31/29175?source=related_link\">",
"      Nonepileptic paroxysmal disorders in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/3/27705?source=related_link\">",
"      Overview of Guillain-Barr&eacute; syndrome in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/35/37433?source=related_link\">",
"      Overview of the hereditary ataxias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/32/12809?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of pediatric multiple sclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/13/38104?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of brain abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/37/30289?source=related_link\">",
"      Patient information: Acute cerebellar ataxia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/20/5450?source=related_link\">",
"      Somatization: Epidemiology, pathogenesis, clinical features, medical evaluation, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/26/3494?source=related_link\">",
"      Tick paralysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/51/41781?source=related_link\">",
"      Treatment of Guillain-Barr&eacute; syndrome in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/15/35062?source=related_link\">",
"      Vestibular neuritis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_45_32473="Epidemiology and etiology of osteoporosis in men";
var content_f31_45_32473=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology and etiology of osteoporosis in men",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/45/32473/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/45/32473/contributors\">",
"     Joel S Finkelstein, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/45/32473/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/45/32473/contributors\">",
"     Clifford J Rosen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/45/32473/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/45/32473/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/45/32473/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 11, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteoporosis is a leading cause of morbidity and mortality in elderly people. While less common in men than women, about 1.5 million men over age 65 years in the United States have osteoporosis and another 3.5 million men are at risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The disorders that cause osteoporosis in men are similar to those in women (",
"    <a class=\"graphic graphic_table graphicRef60440 \" href=\"mobipreview.htm?7/50/7981\">",
"     table 1",
"    </a>",
"    ). Epidemiological surveys suggest that causes or contributing factors for osteoporosis can be identified in 40 to 60 percent of men who have osteoporotic fractures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. Hypogonadism, glucocorticoid therapy, gastrointestinal disease, vitamin D deficiency, anti-convulsant drug therapy, hypercalciuria, and alcohol abuse were among the most common identifiable causes of osteoporosis in these surveys [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/3-6\">",
"     3-6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The epidemiology and etiology of osteoporosis in men will be reviewed here. Fracture risk assessment and the evaluation and treatment of osteoporosis in men are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/42/29354?source=see_link\">",
"     \"Osteoporotic fracture risk assessment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/23/36213?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and evaluation of osteoporosis in men\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/58/31657?source=see_link\">",
"     \"Treatment of osteoporosis in men\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In men, as in women, the incidence of hip fractures increases exponentially with age, although the increase begins approximately 10 years later (",
"    <a class=\"graphic graphic_figure graphicRef58577 \" href=\"mobipreview.htm?6/0/6158\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following observations illustrate the magnitude of the problem in men:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A 60-year-old man has an approximately 25 percent chance of having an osteoporotic fracture during his lifetime [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      By the age of 90 years, one of every six men will have a hip fracture. The prevalence of vertebral or hip fracture in older men is approximately one-third that in women (5 to 6 percent versus 16 to 18 percent), and Colles' fracture one-sixth as common (2.5 percent versus 16 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The mortality rate associated with hip fractures [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/10-13\">",
"       10-13",
"      </a>",
"      ], as well as vertebral and other major fractures [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/14\">",
"       14",
"      </a>",
"      ], is higher in men than in women. In addition, men are even less likely than women to be evaluated or receive antiresorptive therapy after a hip fracture (4.5 versus 49.5 percent, respectively) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/11,15\">",
"       11,15",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/52/39754?source=see_link&amp;anchor=H38#H38\">",
"       \"Overview of the management of osteoporosis in postmenopausal women\", section on 'Medical intervention after fracture'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Decreased bone mass can occur because peak bone mass is low, bone resorption is excessive after peak bone mass is obtained, or bone formation during remodeling is decreased. All three processes are likely to contribute, in varying degrees, to osteoporosis in individual patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/53/3929?source=see_link\">",
"     \"Pathogenesis of osteoporosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Peak bone mass",
"    </span>",
"    &nbsp;&mdash;&nbsp;In men, bone mineral density (BMD) increases markedly during puberty in response to increasing sex steroid production [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Much of this apparent increase, particularly for cortical bone, is due to an increase in bone size. Peak spinal bone density is reached at about 20 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/18-20\">",
"     18-20",
"    </a>",
"    ], while the peak density of the radius and femoral shaft is reached somewhat later [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/19-21\">",
"     19-21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The importance of normal sex steroid production in the acquisition of peak bone mass is illustrated by the findings of low bone mass in young men with idiopathic hypogonadotropic hypogonadism (IHH) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. Because IHH is almost always a congenital abnormality due to GnRH deficiency, this disorder provides a valuable model to assess the effects of hypogonadism on pubertal bone development (ie, the attainment of peak bone mass). Both cortical (",
"    <a class=\"graphic graphic_figure graphicRef69980 \" href=\"mobipreview.htm?4/31/4606\">",
"     figure 2",
"    </a>",
"    ) and trabecular bone density (",
"    <a class=\"graphic graphic_figure graphicRef71184 \" href=\"mobipreview.htm?42/21/43357\">",
"     figure 3",
"    </a>",
"    ) are markedly decreased in these men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. Osteoporosis can be detected even before the attainment of skeletal maturity, suggesting that it is due to inadequate pubertal bone accretion rather than postmaturity bone loss. The clinical manifestations and genetics of IHH are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/7/2170?source=see_link\">",
"     \"Congenital gonadotropin-releasing hormone deficiency (idiopathic hypogonadotropic hypogonadism)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another important determinant of peak bone density is the timing of puberty. In men who experience constitutionally-delayed puberty, bone mineral density of the radial shaft, lumbar spine, and proximal femur is significantly lower as adults than in age-matched normal men, and it does not appear to improve with time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. Similar findings have been reported in adolescent boys with delayed puberty [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/26\">",
"     26",
"    </a>",
"    ]. These observations suggest that there is a critical time period during which the skeleton is responsive to sex steroids.",
"   </p>",
"   <p>",
"    Other factors that determine peak bone mass are genetic predisposition, chronic illnesses, and medications that negatively impact bone density accrual. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/53/3929?source=see_link&amp;anchor=H341616#H341616\">",
"     \"Pathogenesis of osteoporosis\", section on 'Peak bone mass acquisition'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Age-related bone loss",
"    </span>",
"    &nbsp;&mdash;&nbsp;After attainment of peak bone mass, men lose about 30 percent of their trabecular bone and 20 percent of their cortical bone during their lifetimes. The decline in femoral neck density begins shortly after attainment of peak bone mass [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/27,28\">",
"     27,28",
"    </a>",
"    ], and the rate of femoral neck bone loss may increase with aging [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. One study reported that bone mineral content of the proximal and distal radius declines at a rate of approximately 1 percent per year after the age of 30, whereas another study found that cortical BMD remained stable until later in life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/30,31\">",
"     30,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patterns of spine BMD change vary depending upon the measurement technique. When measured by quantitative computed tomography (QCT), which assesses only vertebral body trabecular BMD, spine density declines more rapidly than hip or radius BMD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/30,32\">",
"     30,32",
"    </a>",
"    ]. When spine BMD is measured by dual energy x-ray absorptiometry (DXA) in the posterior-anterior projection, it appears to increase in older men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/29,33,34\">",
"     29,33,34",
"    </a>",
"    ], likely due to degenerative changes in the posterior spinous elements (",
"    <a class=\"graphic graphic_figure graphicRef53843 \" href=\"mobipreview.htm?23/57/24477\">",
"     figure 4",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/33\">",
"     33",
"    </a>",
"    ]. Thus, posterior-anterior DXA is a poor technique for assessing bone density of the spine in older men.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     The role of hormones",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sex steroids play an important role in both peak bone mass acquisition and age-related bone loss. Numerous epidemiologic studies have examined associations between gonadal steroids and bone mineral density or fractures (see below). These studies have reported weak and inconsistent associations, as might be expected when studying different populations and relating a single hormone measurement to complex endpoints like bone density and fracture. Nonetheless, these studies suggest that both estrogens and androgens play important roles in establishing and maintaining bone mass in men. Other hormones, such as parathyroid hormone and insulin-like growth factor 1 (IGF-1), also play a role. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/53/3929?source=see_link&amp;anchor=H341630#H341630\">",
"     \"Pathogenesis of osteoporosis\", section on 'Sex steroid deficiency'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Estrogen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Higher serum estrogen concentrations are associated with higher bone density in men, independent of their serum androgen concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/35-43\">",
"     35-43",
"    </a>",
"    ]. As an example, in the Boston Area Community Health Bone Survey",
"    <span class=\"nowrap\">",
"     (BACH/Bone),",
"    </span>",
"    a cross-sectional study of skeletal health in 1209 ethnically diverse men between the ages of 30 and 79, femoral neck and total hip BMD were associated with total and calculated free estradiol levels; the association remained after multivariate adjustment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. Similarly, in the Osteoporotic Fractures in Men Study (MrOS), a cross-sectional and longitudinal study of 2447 men over age 65 years, the prevalence of osteoporosis in the hip (T-score &lt;-2.5) increased progressively as total or bioavailable estradiol levels fell (",
"    <a class=\"graphic graphic_figure graphicRef68642 \" href=\"mobipreview.htm?34/59/35775\">",
"     figure 5",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/45\">",
"     45",
"    </a>",
"    ]. In addition, low serum estradiol levels are associated with an increased risk of future hip fracture in men; fracture risk appears to be even greater in men with low serum estradiol and testosterone concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/42,46\">",
"     42,46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Longitudinal data suggest that estrogen is also an important determinant of peak bone mass in young men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/42\">",
"     42",
"    </a>",
"    ]. The importance of estrogen in the attainment of peak bone mass is further demonstrated by the finding of osteoporosis in a man with estrogen resistance caused by a loss-of-function mutation in the estrogen receptor gene [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/47\">",
"     47",
"    </a>",
"    ] and in three men with a loss-of-function mutation in the aromatase gene, which results in an inability to convert androgen to estrogen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/48-50\">",
"     48-50",
"    </a>",
"    ]. Estrogen therapy in aromatase deficiency increases bone mass dramatically and reduces markers of bone turnover to normal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/49,50\">",
"     49,50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Testosterone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum testosterone concentrations decrease with age, and this decline may contribute to bone loss by increasing bone resorption or decreasing bone formation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/13/4314?source=see_link\">",
"     \"Overview of testosterone deficiency in elderly men\"",
"    </a>",
"    .) Some cross-sectional studies have failed to detect an association between serum testosterone concentrations and bone density, particularly when other factors (such as age, body size, and serum estradiol concentrations) were considered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/35-40,43,51,52\">",
"     35-40,43,51,52",
"    </a>",
"    ]. In the",
"    <span class=\"nowrap\">",
"     BACH/Bone",
"    </span>",
"    study, for example, BMD at various sites did not correlate with either total or calculated free testosterone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, other studies have reported significant associations between testosterone, free testosterone,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bioavailable testosterone and bone mineral density, rates of bone loss, and prevalent fragility fractures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/45,53,54\">",
"     45,53,54",
"    </a>",
"    ]. As an example, in MrOS the prevalence of osteoporosis in the hip or rapid hip bone loss was threefold higher in men whose total testosterone levels were &lt;200",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    (6.9",
"    <span class=\"nowrap\">",
"     nmol/L)",
"    </span>",
"    compared with &gt;200",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    (",
"    <a class=\"graphic graphic_figure graphicRef68642 \" href=\"mobipreview.htm?34/59/35775\">",
"     figure 5",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Estrogen versus testosterone",
"    </span>",
"    &nbsp;&mdash;&nbsp;To study the relative contributions of sex steroids in the regulation of bone resorption and formation (as measured by urinary and serum markers) in adult men, 59 elderly men (mean age 68 years) received both a gonadotropin-releasing hormone (GnRH) agonist and aromatase inhibitor to eliminate endogenous testosterone and estrogen production, in conjunction with physiologic testosterone and estrogen replacement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/55\">",
"     55",
"    </a>",
"    ]. Bone resorption increased with subsequent withdrawal of the exogenous testosterone, estrogen, or both, with the largest increase observed after selective estrogen withdrawal. The authors concluded that estrogen is the major sex steroid regulating bone resorption, whereas both estrogen and testosterone are important for bone formation.",
"   </p>",
"   <p>",
"    In a similarly-designed study in 70 younger men (ages 20 to 44 years), estrogen and androgens had independent effects on bone resorption, but only androgens had an effect on bone formation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/56\">",
"     56",
"    </a>",
"    ]. Taken together, the data indicate that both androgens and estrogens regulate adult skeletal homeostasis, although the relative magnitude of each hormonal effect is unknown.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Complete androgen insensitivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subjects with complete androgen insensitivity provide a valuable model to assess whether the sexual dimorphism in peak bone density is genetically or hormonally determined. In these subjects, who are genetic males but phenotypic females, radial shaft density is lower than that of normal men but similar to that of normal women. In contrast, lumbar spine (LS) density is lower than expected for either men or women of the same age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/57-59\">",
"     57-59",
"    </a>",
"    ]. These findings suggests that androgen action contributes to the normal sexual dimorphism in cortical bone density and that the Y chromosome, per se, is not sufficient to guarantee the higher cortical density of normal men. Insufficient replacement of estradiol after gonadectomy, however, cannot be excluded as a reason for these results. As an example, in one study, noncompliance with estrogen replacement therapy after gonadectomy correlated with lower LS bone density [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/58\">",
"     58",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/5/22616?source=see_link\">",
"     \"Clinical manifestations and pathogenesis of disorders of the androgen receptor\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Other hormones",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other hormonal changes that may be associated with age-related bone loss include higher serum parathyroid hormone (PTH) concentrations and lower serum 25-hydroxyvitamin D and insulin-like growth factor-1 concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/38,60,61\">",
"     38,60,61",
"    </a>",
"    ]. Suppression of gonadal steroids in elderly men with a GnRH agonist increases the skeletal responsiveness to pharmacologic doses of exogenous PTH, an observation that might help to explain bone loss in men with hypogonadism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to low peak bone mass and age-related bone loss, a number of factors contribute to the development of osteoporosis and fracture in men. In a meta-analysis of 55 observational studies, low BMI, excessive alcohol intake (daily intake or &gt;10 servings per week), current smoking, chronic corticosteroid use, history of prior fractures, history of falls within the past year, hypogonadism, history of cerebrovascular accident, and history of diabetes were significantly associated with low bone density-related fractures in men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several endocrine, gastrointestinal, and hematologic disorders are also associated with osteoporosis. The medical disorders that cause osteoporosis in men are similar to those in women (",
"    <a class=\"graphic graphic_table graphicRef60440 \" href=\"mobipreview.htm?7/50/7981\">",
"     table 1",
"    </a>",
"    ). Epidemiological surveys suggest that causes for osteoporosis can be identified in 40 to 60 percent of men who have osteoporotic fractures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. Hypogonadism, glucocorticoid therapy, gastrointestinal disease, vitamin D deficiency, anti-convulsant drug therapy, hypercalciuria, and alcohol abuse were among the most common identifiable causes of osteoporosis in these surveys [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/3-6\">",
"     3-6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Brief comments on some of these risk factors follow; more detailed reviews are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/54/42855?source=see_link\">",
"     \"Pathogenesis, clinical features, and evaluation of glucocorticoid-induced osteoporosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/11/17593?source=see_link\">",
"     \"Bone disease with hyperthyroidism and thyroid hormone therapy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/26/11687?source=see_link\">",
"     \"Bone disease in diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/54/30569?source=see_link\">",
"     \"Metabolic bone disease in inflammatory bowel disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/21/9562?source=see_link\">",
"     \"Drugs that affect bone metabolism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Lifestyle factors",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Smoking and alcohol",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both cigarette smoking and excess alcohol intake are associated with increased rates of bone loss and fracture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/42/29354?source=see_link&amp;anchor=H23#H23\">",
"     \"Osteoporotic fracture risk assessment\", section on 'Cigarette smoking'",
"    </a>",
"    .) Alcohol intake is inversely associated with bone density in men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/65,66\">",
"     65,66",
"    </a>",
"    ], and osteoporotic fractures are common in alcoholic men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/4,67\">",
"     4,67",
"    </a>",
"    ]. The mechanism whereby alcohol reduces bone density is unknown, but appears to be related to decreased bone formation. Abnormalities in vitamin D metabolism, parathyroid function, or gonadal function may also contribute to alcohol-related bone loss, although the evidence that any of these factors plays an important role is not convincing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Calcium and vitamin D",
"    </span>",
"    &nbsp;&mdash;&nbsp;In observational studies, vitamin D deficiency is associated with osteoporosis, poor physical performance, and an increased risk of fractures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/5,60,68\">",
"     5,60,68",
"    </a>",
"    ]. Evidence supporting the benefit of calcium and vitamin D supplementation in men with osteoporosis comes largely from prospective, randomized, placebo-controlled trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. Although a number of trials have reported a beneficial effect of calcium or calcium plus vitamin D on bone density in postmenopausal women and older men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/69-73\">",
"     69-73",
"    </a>",
"    ], the data on fracture rates are more variable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/74\">",
"     74",
"    </a>",
"    ]. This topic is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/56/12170?source=see_link&amp;anchor=H2#H2\">",
"     \"Calcium and vitamin D supplementation in osteoporosis\", section on 'Efficacy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Physical activity and strength",
"    </span>",
"    &nbsp;&mdash;&nbsp;Low levels of physical activity are associated with bone loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/2,75-77\">",
"     2,75-77",
"    </a>",
"    ] and a higher risk of fracture in older men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/78-81\">",
"     78-81",
"    </a>",
"    ]. As an example, in a cohort study of 2205 men aged 49 to 51 years, low or medium levels of physical activity were associated with more than a twofold higher risk of fracture, including hip fracture, compared with high physical activity (HR for hip fracture in low or medium activity compared with high activity groups 2.31, 95% CI 1.39-3.85) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Body weight",
"    </span>",
"    &nbsp;&mdash;&nbsp;Body weight is associated with bone density in older men, and weight loss appears to increase the rate of hip bone loss, even in obese men undergoing voluntary weight reduction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Hypogonadism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypogonadism is the best-characterized risk factor for osteoporosis in men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/3,4,77,83,84\">",
"     3,4,77,83,84",
"    </a>",
"    ]. Cross-sectional studies demonstrate that bone mineral density is reduced in men with primary or secondary hypogonadism (",
"    <a class=\"graphic graphic_figure graphicRef64482 \" href=\"mobipreview.htm?34/38/35437\">",
"     figure 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/22,85-89\">",
"     22,85-89",
"    </a>",
"    ], men with constitutional delay of puberty [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/24,25\">",
"     24,25",
"    </a>",
"    ], IHH [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/22,23\">",
"     22,23",
"    </a>",
"    ], and subjects with androgen insensitivity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/52/30536?source=see_link\">",
"     \"Causes of primary hypogonadism in males\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/18/8488?source=see_link\">",
"     \"Causes of secondary hypogonadism in males\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/44/17096?source=see_link\">",
"     \"Diagnosis and treatment of disorders of the androgen receptor\"",
"    </a>",
"    .) The low bone density appears to be due to testosterone",
"    <span class=\"nowrap\">",
"     (and/or",
"    </span>",
"    estradiol) deficiency, rather than dihydrotestosterone deficiency, as men treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/24/39301?source=see_link\">",
"     finasteride",
"    </a>",
"    , which inhibits conversion of testosterone to dihydrotestosterone, do not have accelerated bone loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/90\">",
"     90",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Osteoporosis has also been reported in hypogonadal men with hemochromatosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/86,91\">",
"     86,91",
"    </a>",
"    ] and anorexia nervosa [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/92\">",
"     92",
"    </a>",
"    ]. In these men, it is difficult to determine whether the osteopenia is due to concomitant liver disease and nutritional deficiencies or to hypogonadism. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/60/28617?source=see_link\">",
"     \"Clinical manifestations of hereditary hemochromatosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There have been few longitudinal studies of men at risk for osteoporosis as a result of hypogonadism. Bone density decreases in young men who are castrated for sexual delinquency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/93\">",
"     93",
"    </a>",
"    ] and in older men with advanced prostate cancer who undergo androgen ablation therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/94-97\">",
"     94-97",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/30/21993?source=see_link&amp;anchor=H7#H7\">",
"     \"Side effects of androgen deprivation therapy\", section on 'Osteoporosis and bone fractures'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Severe hypogonadism increases the risk of fractures in men:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study of 235 men with prostate cancer, 14 percent of those treated with orchiectomy (n = 59) later had osteoporotic fractures, compared with 1 percent in those who did not undergo orchiectomy (n =176) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/98\">",
"       98",
"      </a>",
"      ]. Among the 16 men who survived for at least five years after orchiectomy, six (38 percent) had a nontraumatic fracture that was not attributable to their cancer.",
"     </li>",
"     <li>",
"      The increase in fracture risk with androgen deprivation therapy (rather than orchiectomy) may be more modest. This was illustrated in a much larger study of 50,613 men with a diagnosis of prostate cancer; 19 percent of 6650 men who survived at least five years after diagnosis (and who received androgen-deprivation therapy) had a fracture (compared to 12 percent of the 20,035 patients who did not receive androgen-deprivation therapy) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/99\">",
"       99",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Reduction in bone mineral density can be detected after as little as six to nine months of androgen deprivation therapy. Thus, all men beginning such therapy should receive calcium and vitamin D and maintain a moderate exercise regimen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/100\">",
"     100",
"    </a>",
"    ]. Treatment with calcium and vitamin D alone, however, is not sufficient to prevent bone loss in these men. Baseline measurement of bone density and periodic reassessment during therapy are appropriate, and bisphosphonate therapy should be considered. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/58/31657?source=see_link\">",
"     \"Treatment of osteoporosis in men\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/30/21993?source=see_link&amp;anchor=H7#H7\">",
"     \"Side effects of androgen deprivation therapy\", section on 'Osteoporosis and bone fractures'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Growth hormone deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;In some studies, bone mineral density of the lumbar spine is somewhat lower in untreated patients with adult-onset growth hormone deficiency compared with normal subjects. The degree of osteopenia appears to correlate directly with the degree of growth hormone deficiency. Bone mineral density often increases following growth hormone therapy. The skeletal effects of growth hormone deficiency are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/50/1833?source=see_link&amp;anchor=H7#H7\">",
"     \"Growth hormone deficiency in adults\", section on 'Bone mineral density'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Glucocorticoid excess",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both endogenous and exogenous glucocorticoid excess cause osteoporosis in men as well as in women. The osteoporosis is due primarily to the effects of glucocorticoid excess on bone, but glucocorticoid-induced hypogonadism may be a contributory factor. Glucocorticoid excess, which is nearly always caused by exogenous glucocorticoid therapy, is responsible for approximately 15 percent of vertebral fractures in men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/4,101\">",
"     4,101",
"    </a>",
"    ], but some of the bone disease may be due to the underlying disorders for which glucocorticoids are given, rather than the glucocorticoid therapy itself. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/54/42855?source=see_link\">",
"     \"Pathogenesis, clinical features, and evaluation of glucocorticoid-induced osteoporosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Hypercalciuria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Men with hypercalciuria may have lower bone mineral density than expected for age, particularly those in whom hypercalciuria persists despite a low calcium diet [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/102-107\">",
"     102-107",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Idiopathic osteoporosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 40 to 60 percent of men with osteoporosis in whom a cause cannot be identified are said to have idiopathic osteoporosis. Histomorphometric studies suggest that many have diminished bone formation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/108-110\">",
"     108-110",
"    </a>",
"    ], but some have increased bone resorption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/111\">",
"     111",
"    </a>",
"    ]. Many of these men probably have a genetic predisposition to osteoporosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32473/abstract/112\">",
"     112",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serum IGF-1 concentrations are low in some men with idiopathic osteoporosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/5/34906?source=see_link&amp;anchor=H1206170#H1206170\">",
"     \"Normal skeletal development and regulation of bone formation and resorption\", section on 'Growth hormone and IGFs'",
"    </a>",
"    .) Approximately 2 to 3 percent of men have a history of delayed puberty, which could be a precursor of idiopathic osteoporosis. Estrogen deficiency may also be responsible for otherwise unexplained osteoporosis in some men.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In men, as in women, the incidence of fragility fractures increases exponentially with age, although the increase begins approximately 10 years later. However, the mortality rate associated with hip fractures, as well as vertebral and other major fractures, is higher in men than in women. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Low bone mass in men may be due to suboptimal peak bone mass acquisition, ongoing bone loss, or reduced bone formation during remodeling. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In addition to low peak bone mass and age-related bone loss, a number of factors contribute to the development of osteoporosis and fracture in men, including smoking and chronic corticosteroid use. A history of prior fractures and history of falls within the past year are powerful predictors of future fractures. A cause for osteoporosis can be identified in 40 to 60 percent of men who have osteoporotic fractures. Hypogonadism, glucocorticoid therapy, gastrointestinal disease, vitamin D deficiency, anti-convulsant drug therapy, hypercalciuria, and alcohol abuse are among the most common identifiable causes of osteoporosis in men (",
"      <a class=\"graphic graphic_table graphicRef60440 \" href=\"mobipreview.htm?7/50/7981\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/1\">",
"      Siddiqui NA, Shetty KR, Duthie EH Jr. Osteoporosis in older men: discovering when and how to treat it. Geriatrics 1999; 54:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/2\">",
"      Orwoll ES, Klein RF. Osteoporosis in men. Endocr Rev 1995; 16:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/3\">",
"      Kelepouris N, Harper KD, Gannon F, et al. Severe osteoporosis in men. Ann Intern Med 1995; 123:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/4\">",
"      Seeman E, Melton LJ 3rd, O'Fallon WM, Riggs BL. Risk factors for spinal osteoporosis in men. Am J Med 1983; 75:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/5\">",
"      Diamond T, Smerdely P, Kormas N, et al. Hip fracture in elderly men: the importance of subclinical vitamin D deficiency and hypogonadism. Med J Aust 1998; 169:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/6\">",
"      Scane AC, Francis RM, Sutcliffe AM, et al. Case-control study of the pathogenesis and sequelae of symptomatic vertebral fractures in men. Osteoporos Int 1999; 9:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/7\">",
"      Farmer ME, White LR, Brody JA, Bailey KR. Race and sex differences in hip fracture incidence. Am J Public Health 1984; 74:1374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/8\">",
"      Nguyen TV, Eisman JA, Kelly PJ, Sambrook PN. Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol 1996; 144:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/9\">",
"      Melton, LJ III, Chrischilles, EA, Cooper, C, et al. How many women have osteoporosis? J Bone Miner Res 1992; 7:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/10\">",
"      Diamond TH, Thornley SW, Sekel R, Smerdely P. Hip fracture in elderly men: prognostic factors and outcomes. Med J Aust 1997; 167:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/11\">",
"      Kiebzak GM, Beinart GA, Perser K, et al. Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med 2002; 162:2217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/12\">",
"      Kanis JA, Oden A, Johnell O, et al. The components of excess mortality after hip fracture. Bone 2003; 32:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/13\">",
"      Trombetti A, Herrmann F, Hoffmeyer P, et al. Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporos Int 2002; 13:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/14\">",
"      Center JR, Nguyen TV, Schneider D, et al. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 1999; 353:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/15\">",
"      Feldstein A, Elmer PJ, Orwoll E, et al. Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation. Arch Intern Med 2003; 163:2165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/16\">",
"      Krabbe S, Christiansen C. Longitudinal study of calcium metabolism in male puberty. I. Bone mineral content, and serum levels of alkaline phosphatase, phosphate and calcium. Acta Paediatr Scand 1984; 73:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/17\">",
"      Krabbe S, Hummer L, Christiansen C. Longitudinal study of calcium metabolism in male puberty. II. Relationship between mineralization and serum testosterone. Acta Paediatr Scand 1984; 73:750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/18\">",
"      Gilsanz V, Gibbens DT, Roe TF, et al. Vertebral bone density in children: effect of puberty. Radiology 1988; 166:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/19\">",
"      Bonjour JP, Theintz G, Buchs B, et al. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab 1991; 73:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/20\">",
"      Theintz G, Buchs B, Rizzoli R, et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 1992; 75:1060.",
"     </a>",
"    </li>",
"    <li>",
"     Mazess, RB, Cameron, JR. Bone mineral content in normal U.S. whites. In: Proceedings, International Conference on Bone Mineral Measurement. Mazess, RB (Ed). DHEW Publication NIH 75-683, Washington, D.C. 1974; 228.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/22\">",
"      Finkelstein JS, Klibanski A, Neer RM, et al. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med 1987; 106:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/23\">",
"      Guo CY, Jones TH, Eastell R. Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover. J Clin Endocrinol Metab 1997; 82:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/24\">",
"      Finkelstein JS, Neer RM, Biller BM, et al. Osteopenia in men with a history of delayed puberty. N Engl J Med 1992; 326:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/25\">",
"      Finkelstein JS, Klibanski A, Neer RM. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. J Clin Endocrinol Metab 1996; 81:1152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/26\">",
"      Bertelloni S, Baroncelli GI, Battini R, et al. Short-term effect of testosterone treatment on reduced bone density in boys with constitutional delay of puberty. J Bone Miner Res 1995; 10:1488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/27\">",
"      Nordstr&ouml;m P, Neovius M, Nordstr&ouml;m A. Early and rapid bone mineral density loss of the proximal femur in men. J Clin Endocrinol Metab 2007; 92:1902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/28\">",
"      Berger C, Langsetmo L, Joseph L, et al. Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. CMAJ 2008; 178:1660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/29\">",
"      Jones G, Nguyen T, Sambrook P, et al. Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ 1994; 309:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/30\">",
"      Orwoll ES, Oviatt SK, McClung MR, et al. The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation. Ann Intern Med 1990; 112:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/31\">",
"      Riggs BL, Melton LJ, Robb RA, et al. A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res 2008; 23:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/32\">",
"      Meier DE, Orwoll ES, Jones JM. Marked disparity between trabecular and cortical bone loss with age in healthy men. Measurement by vertebral computed tomography and radial photon absorptiometry. Ann Intern Med 1984; 101:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/33\">",
"      Zmuda JM, Cauley JA, Glynn NW, Finkelstein JS. Posterior-anterior and lateral dual-energy x-ray absorptiometry for the assessment of vertebral osteoporosis and bone loss among older men. J Bone Miner Res 2000; 15:1417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/34\">",
"      Orwoll ES, Oviatt SK, Mann T. The impact of osteophytic and vascular calcifications on vertebral mineral density measurements in men. J Clin Endocrinol Metab 1990; 70:1202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/35\">",
"      Slemenda CW, Longcope C, Zhou L, et al. Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens. J Clin Invest 1997; 100:1755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/36\">",
"      Khosla S, Melton LJ 3rd, Atkinson EJ, et al. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 1998; 83:2266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/37\">",
"      Ongphiphadhanakul B, Rajatanavin R, Chanprasertyothin S, et al. Serum oestradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males. Clin Endocrinol (Oxf) 1998; 49:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/38\">",
"      Center JR, Nguyen TV, Sambrook PN, Eisman JA. Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. J Clin Endocrinol Metab 1999; 84:3626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/39\">",
"      Greendale GA, Edelstein S, Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. J Bone Miner Res 1997; 12:1833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/40\">",
"      Amin S, Zhang Y, Sawin CT, et al. Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Ann Intern Med 2000; 133:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/41\">",
"      Szulc P, Munoz F, Claustrat B, et al. Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. J Clin Endocrinol Metab 2001; 86:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/42\">",
"      Khosla S, Melton LJ 3rd, Atkinson EJ, O'Fallon WM. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab 2001; 86:3555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/43\">",
"      Araujo AB, Travison TG, Leder BZ, McKinlay JB. Correlations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of men. J Clin Endocrinol Metab 2008; 93:2135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/44\">",
"      Araujo AB, Travison TG, Harris SS, et al. Race/ethnic differences in bone mineral density in men. Osteoporos Int 2007; 18:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/45\">",
"      Fink HA, Ewing SK, Ensrud KE, et al. Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab 2006; 91:3908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/46\">",
"      Amin S, Zhang Y, Felson DT, et al. Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study. Am J Med 2006; 119:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/47\">",
"      Smith EP, Boyd J, Frank GR, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994; 331:1056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/48\">",
"      Morishima A, Grumbach MM, Simpson ER, et al. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995; 80:3689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/49\">",
"      Carani C, Qin K, Simoni M, et al. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 1997; 337:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/50\">",
"      Bilezikian JP, Morishima A, Bell J, Grumbach MM. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 1998; 339:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/51\">",
"      Meier DE, Orwoll ES, Keenan EJ, Fagerstrom RM. Marked decline in trabecular bone mineral content in healthy men with age: lack of association with sex steroid levels. J Am Geriatr Soc 1987; 35:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/52\">",
"      Rudman D, Drinka PJ, Wilson CR, et al. Relations of endogenous anabolic hormones and physical activity to bone mineral density and lean body mass in elderly men. Clin Endocrinol (Oxf) 1994; 40:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/53\">",
"      Mellstr&ouml;m D, Johnell O, Ljunggren O, et al. Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res 2006; 21:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/54\">",
"      Ensrud KE, Lewis CE, Lambert LC, et al. Endogenous sex steroids, weight change and rates of hip bone loss in older men: the MrOS study. Osteoporos Int 2006; 17:1329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/55\">",
"      Falahati-Nini A, Riggs BL, Atkinson EJ, et al. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 2000; 106:1553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/56\">",
"      Leder BZ, LeBlanc KM, Schoenfeld DA, et al. Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab 2003; 88:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/57\">",
"      Bertelloni S, Baroncelli GI, Federico G, et al. Altered bone mineral density in patients with complete androgen insensitivity syndrome. Horm Res 1998; 50:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/58\">",
"      Marcus R, Leary D, Schneider DL, et al. The contribution of testosterone to skeletal development and maintenance: lessons from the androgen insensitivity syndrome. J Clin Endocrinol Metab 2000; 85:1032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/59\">",
"      Sobel V, Schwartz B, Zhu YS, et al. Bone mineral density in the complete androgen insensitivity and 5alpha-reductase-2 deficiency syndromes. J Clin Endocrinol Metab 2006; 91:3017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/60\">",
"      Orwoll ES, Meier DE. Alterations in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging: relationship to the development of senile osteopenia. J Clin Endocrinol Metab 1986; 63:1262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/61\">",
"      Rapado A, Hawkins F, Sobrinho L, et al. Bone mineral density and androgen levels in elderly males. Calcif Tissue Int 1999; 65:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/62\">",
"      Leder BZ, Smith MR, Fallon MA, et al. Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men. J Clin Endocrinol Metab 2001; 86:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/63\">",
"      Drake MT, Murad MH, Mauck KF, et al. Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis. J Clin Endocrinol Metab 2012; 97:1861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/64\">",
"      Jutberger H, Lorentzon M, Barrett-Connor E, et al. Smoking predicts incident fractures in elderly men: Mr OS Sweden. J Bone Miner Res 2010; 25:1010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/65\">",
"      Slemenda CW, Christian JC, Reed T, et al. Long-term bone loss in men: effects of genetic and environmental factors. Ann Intern Med 1992; 117:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/66\">",
"      Dal&eacute;n N, Lamke B. Bone mineral losses in alcoholics. Acta Orthop Scand 1976; 47:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/67\">",
"      Spencer H, Rubio N, Rubio E, et al. Chronic alcoholism. Frequently overlooked cause of osteoporosis in men. Am J Med 1986; 80:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/68\">",
"      Wicherts IS, van Schoor NM, Boeke AJ, et al. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 2007; 92:2058.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/69\">",
"      Daly RM, Brown M, Bass S, et al. Calcium- and vitamin D3-fortified milk reduces bone loss at clinically relevant skeletal sites in older men: a 2-year randomized controlled trial. J Bone Miner Res 2006; 21:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/70\">",
"      Meier C, Woitge HW, Witte K, et al. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res 2004; 19:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/71\">",
"      Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997; 337:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/72\">",
"      Reid IR, Ames R, Mason B, et al. Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men. Arch Intern Med 2008; 168:2276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/73\">",
"      Peacock M, Liu G, Carey M, et al. Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab 2000; 85:3011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/74\">",
"      Cranney A, Weiler HA, O'Donnell S, Puil L. Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. Am J Clin Nutr 2008; 88:513S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/75\">",
"      Snow-Harter C, Whalen R, Myburgh K, et al. Bone mineral density, muscle strength, and recreational exercise in men. J Bone Miner Res 1992; 7:1291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/76\">",
"      Greendale GA, Barrett-Connor E, Edelstein S, et al. Lifetime leisure exercise and osteoporosis. The Rancho Bernardo study. Am J Epidemiol 1995; 141:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/77\">",
"      Jackson JA, Kleerekoper M. Osteoporosis in men: diagnosis, pathophysiology, and prevention. Medicine (Baltimore) 1990; 69:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/78\">",
"      Kujala UM, Kaprio J, Kannus P, et al. Physical activity and osteoporotic hip fracture risk in men. Arch Intern Med 2000; 160:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/79\">",
"      Paganini-Hill A, Chao A, Ross RK, Henderson BE. Exercise and other factors in the prevention of hip fracture: the Leisure World study. Epidemiology 1991; 2:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/80\">",
"      Joakimsen RM, F&oslash;nneb&oslash; V, Magnus JH, et al. The Troms&oslash; Study: physical activity and the incidence of fractures in a middle-aged population. J Bone Miner Res 1998; 13:1149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/81\">",
"      Micha&euml;lsson K, Olofsson H, Jensevik K, et al. Leisure physical activity and the risk of fracture in men. PLoS Med 2007; 4:e199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/82\">",
"      Ensrud KE, Fullman RL, Barrett-Connor E, et al. Voluntary weight reduction in older men increases hip bone loss: the osteoporotic fractures in men study. J Clin Endocrinol Metab 2005; 90:1998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/83\">",
"      Stanley HL, Schmitt BP, Poses RM, Deiss WP. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? J Am Geriatr Soc 1991; 39:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/84\">",
"      Jackson JA, Riggs MW, Spiekerman AM. Testosterone deficiency as a risk factor for hip fractures in men: a case-control study. Am J Med Sci 1992; 304:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/85\">",
"      Stoch SA, Parker RA, Chen L, et al. Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab 2001; 86:2787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/86\">",
"      Diamond T, Stiel D, Posen S. Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors? Ann Intern Med 1989; 110:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/87\">",
"      Katznelson L, Finkelstein JS, Schoenfeld DA, et al. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab 1996; 81:4358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/88\">",
"      Behre HM, Kliesch S, Leifke E, et al. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 1997; 82:2386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/89\">",
"      Finkelstein JS, Klibanski A, Neer RM, et al. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1989; 69:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/90\">",
"      Matzkin H, Chen J, Weisman Y, et al. Prolonged treatment with finasteride (a 5 alpha-reductase inhibitor) does not affect bone density and metabolism. Clin Endocrinol (Oxf) 1992; 37:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/91\">",
"      Diamond T, Stiel D, Posen S. Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis. J Bone Miner Res 1991; 6:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/92\">",
"      Andersen AE, Watson T, Schlechte J. Osteoporosis and osteopenia in men with eating disorders. Lancet 2000; 355:1967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/93\">",
"      Stp&aacute;n JJ, Lachman M, Zvrina J, et al. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab 1989; 69:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/94\">",
"      Chen Z, Maricic M, Nguyen P, et al. Low bone density and high percentage of body fat among men who were treated with androgen deprivation therapy for prostate carcinoma. Cancer 2002; 95:2136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/95\">",
"      Smith MR, McGovern FJ, Zietman AL, et al. Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer. N Engl J Med 2001; 345:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/96\">",
"      Maillefert JF, Sibilia J, Michel F, et al. Bone mineral density in men treated with synthetic gonadotropin-releasing hormone agonists for prostatic carcinoma. J Urol 1999; 161:1219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/97\">",
"      Mittan D, Lee S, Miller E, et al. Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs. J Clin Endocrinol Metab 2002; 87:3656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/98\">",
"      Daniell HW. Osteoporosis after orchiectomy for prostate cancer. J Urol 1997; 157:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/99\">",
"      Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 2005; 352:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/100\">",
"      Ross RW, Small EJ. Osteoporosis in men treated with androgen deprivation therapy for prostate cancer. J Urol 2002; 167:1952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/101\">",
"      Francis RM, Peacock M, Marshall DH, et al. Spinal osteoporosis in men. Bone Miner 1989; 5:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/102\">",
"      Pacifici R, Rothstein M, Rifas L, et al. Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab 1990; 71:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/103\">",
"      Weisinger JR, Alonzo E, Bellor&iacute;n-Font E, et al. Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 1996; 49:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/104\">",
"      Ghazali A, Fuent&egrave;s V, Desaint C, et al. Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 1997; 82:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/105\">",
"      Bataille P, Achard JM, Fournier A, et al. Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int 1991; 39:1193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/106\">",
"      Borghi L, Meschi T, Guerra A, et al. Vertebral mineral content in diet-dependent and diet-independent hypercalciuria. J Urol 1991; 146:1334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/107\">",
"      Vezzoli G, Soldati L, Arcidiacono T, et al. Urinary calcium is a determinant of bone mineral density in elderly men participating in the InCHIANTI study. Kidney Int 2005; 67:2006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/108\">",
"      Kurland ES, Rosen CJ, Cosman F, et al. Insulin-like growth factor-I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 1997; 82:2799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/109\">",
"      Hills E, Dunstan CR, Wong SY, Evans RA. Bone histology in young adult osteoporosis. J Clin Pathol 1989; 42:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/110\">",
"      de Vernejoul MC, Bielakoff J, Herve M, et al. Evidence for defective osteoblastic function. A role for alcohol and tobacco consumption in osteoporosis in middle-aged men. Clin Orthop Relat Res 1983; :107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/111\">",
"      Nordin BE, Aaron J, Speed R, et al. Bone formation and resorption as the determinants of trabecular bone volume in normal and osteoporotic men. Scott Med J 1984; 29:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32473/abstract/112\">",
"      Van Pottelbergh I, Goemaere S, Zmierczak H, et al. Deficient acquisition of bone during maturation underlies idiopathic osteoporosis in men: evidence from a three-generation family study. J Bone Miner Res 2003; 18:303.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2049 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-213.134.24.46-FA3CAE7412-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_45_32473=[""].join("\n");
var outline_f31_45_32473=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Peak bone mass",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Age-related bone loss",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      The role of hormones",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Estrogen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Testosterone",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Estrogen versus testosterone",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Complete androgen insensitivity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Other hormones",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Lifestyle factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Smoking and alcohol",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Calcium and vitamin D",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Physical activity and strength",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Body weight",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Hypogonadism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Growth hormone deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Glucocorticoid excess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Hypercalciuria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Idiopathic osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/2049\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/2049|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?6/0/6158\" title=\"figure 1\">",
"      Average annual fracture rate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?4/31/4606\" title=\"figure 2\">",
"      Radial bone density IHH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?42/21/43357\" title=\"figure 3\">",
"      Spinal BMD with IHH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?23/57/24477\" title=\"figure 4\">",
"      Percent change BMD older men",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?34/59/35775\" title=\"figure 5\">",
"      Op hip and gonadal steroids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?34/38/35437\" title=\"figure 6\">",
"      Trabecular BMD hypogonadism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/2049|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/50/7981\" title=\"table 1\">",
"      Causes of osteoporosis men",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/26/11687?source=related_link\">",
"      Bone disease in diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/11/17593?source=related_link\">",
"      Bone disease with hyperthyroidism and thyroid hormone therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/56/12170?source=related_link\">",
"      Calcium and vitamin D supplementation in osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/52/30536?source=related_link\">",
"      Causes of primary hypogonadism in males",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/18/8488?source=related_link\">",
"      Causes of secondary hypogonadism in males",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/5/22616?source=related_link\">",
"      Clinical manifestations and pathogenesis of disorders of the androgen receptor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/60/28617?source=related_link\">",
"      Clinical manifestations of hereditary hemochromatosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/23/36213?source=related_link\">",
"      Clinical manifestations, diagnosis, and evaluation of osteoporosis in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/7/2170?source=related_link\">",
"      Congenital gonadotropin-releasing hormone deficiency (idiopathic hypogonadotropic hypogonadism)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/44/17096?source=related_link\">",
"      Diagnosis and treatment of disorders of the androgen receptor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/21/9562?source=related_link\">",
"      Drugs that affect bone metabolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/50/1833?source=related_link\">",
"      Growth hormone deficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/54/30569?source=related_link\">",
"      Metabolic bone disease in inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/5/34906?source=related_link\">",
"      Normal skeletal development and regulation of bone formation and resorption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/42/29354?source=related_link\">",
"      Osteoporotic fracture risk assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/13/4314?source=related_link\">",
"      Overview of testosterone deficiency in elderly men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/52/39754?source=related_link\">",
"      Overview of the management of osteoporosis in postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/53/3929?source=related_link\">",
"      Pathogenesis of osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/54/42855?source=related_link\">",
"      Pathogenesis, clinical features, and evaluation of glucocorticoid-induced osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/30/21993?source=related_link\">",
"      Side effects of androgen deprivation therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/58/31657?source=related_link\">",
"      Treatment of osteoporosis in men",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_45_32474="Pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis";
var content_f31_45_32474=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/45/32474/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/45/32474/contributors\">",
"     Peter A L Bonis, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/45/32474/contributors\">",
"     Glenn T Furuta, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/45/32474/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/45/32474/contributors\">",
"     Nicholas J Talley, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/45/32474/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/45/32474/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/45/32474/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 9, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Esophageal eosinophils were once considered to be a hallmark of gastroesophageal reflux disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/1\">",
"     1",
"    </a>",
"    ]. However, it has become apparent that the esophagus, which is normally devoid of eosinophils, is an immunologically active organ that is capable of recruiting eosinophils in response to a variety of stimuli [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Esophageal eosinophilia has been described in association with eosinophilic gastroenteritis, an uncommon condition that can cause a range of symptoms, including malabsorption, dysmotility, and ascites, depending upon the layer of the intestinal tract that is involved [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. When the gastrointestinal eosinophilia is limited to the esophagus, is accompanied by characteristic symptoms, and other causes of eosinophilia have been ruled out, it is termed eosinophilic esophagitis. In the past, eosinophilic esophagitis was abbreviated as \"EE\" but, because of confusion with erosive esophagitis, many prefer the abbreviation \"EoE\".",
"   </p>",
"   <p>",
"    A panel of experts defined eosinophilic esophagitis as \"a chronic,",
"    <span class=\"nowrap\">",
"     immune/antigen-mediated,",
"    </span>",
"    esophageal disease characterized clinically by symptoms related to esophageal dysfunction and histologically by eosinophil-predominant inflammation\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/6\">",
"     6",
"    </a>",
"    ]. It is important to differentiate between eosinophilic esophagitis, which is a clinicopathologic diagnosis, and esophageal eosinophilia in the absence of characteristic symptoms, which can be seen in association with multiple conditions. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    This topic will review the pathogenesis, clinical manifestations, and diagnosis of eosinophilic esophagitis in adults and children. Eosinophilic gastroenteritis, other diseases with eosinophilic involvement of specific organs, and the treatment of eosinophilic esophagitis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/43/43703?source=see_link\">",
"     \"Eosinophilic gastroenteritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/37/40535?source=see_link\">",
"     \"Diseases with eosinophilic involvement of specific organs\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/16/44297?source=see_link\">",
"     \"Treatment of eosinophilic esophagitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eosinophilic esophagitis has been reported in several countries in North and South America, Europe, Asia, and Australia, but there have been no published reports from countries in Africa. A study of a pathology database from the United States found that the disease has been detected in most states that reported data [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/7\">",
"     7",
"    </a>",
"    ]. The results of one survey suggested there may be regional variation, with a higher prevalence in northeastern states and lower prevalence in western states [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/8\">",
"     8",
"    </a>",
"    ]. The diagnosis also appears to be more common in urban as opposed to rural settings. Prevalence within the United States may also differ between climate zones with a higher prevalence in cold and arid zones as compared with the tropical zones [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The first cases of probable eosinophilic esophagitis were reported in the late 1960s to 1970s [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. Early reports (mostly from the 1990s) described patients with multiple esophageal rings, which were attributed to gastroesophageal reflux disease or a congenital origin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/10,13-18\">",
"     10,13-18",
"    </a>",
"    ]. The assumed association with gastroesophageal reflux disease (GERD) was based upon the observation that biopsies from patients with a ringed esophagus had basal zone hyperplasia, papillary lengthening, and intraepithelial eosinophils, findings that are seen in patients with documented reflux disease. However, careful review of these reports has raised questions about the association with GERD, since many of the patients did not respond to antisecretory therapy or have objective evidence of reflux on a 24-hour pH study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/13,19\">",
"     13,19",
"    </a>",
"    ]. In addition, esophageal dilation in some of these patients was associated with deep mucosal tears and esophageal perforation, complications also seen in patients with eosinophilic esophagitis who undergo dilation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/14-16,18,20-24\">",
"     14-16,18,20-24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incidence of eosinophilic esophagitis appears to be increasing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/25-28\">",
"     25-28",
"    </a>",
"    ]. Some of the increase may be due to increased recognition of the disorder, but increased recognition is unlikely to fully account for the rising incidence. One reason that increased recognition is unlikely to be the sole explanation is that gastrointestinal",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    radiography has been practiced for many decades and it is likely that the characteristic ringed pattern in the esophagus would have been described earlier. While studies evaluating the prevalence of eosinophilic esophagitis in biopsy samples from patients undergoing endoscopy have not detected an increase since at least the late 1980s [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/29,30\">",
"     29,30",
"    </a>",
"    ], population-based studies have supported an increasing incidence:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A population-based study evaluated the incidence of eosinophilic esophagitis in Olmsted County Minnesota over thirty years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/31\">",
"       31",
"      </a>",
"      ]. The incidence increased significantly during the last three of the five-year intervals examined (from 0.35 per 100,000 population between 1991 and 1995 to 9.45 per 100,000 between 2001 and 2005). The prevalence was estimated to be 55 per 100,000 in 2006.",
"     </li>",
"     <li>",
"      Two population-based studies from Switzerland concluded that the incidence of eosinophilic esophagitis was increasing and, in one study, the incidence was approaching that of inflammatory bowel disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/26,32\">",
"       26,32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A population-based study in children focused on 103 patients who had been identified from a single institution's pathology database in Hamilton County, Ohio [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/25\">",
"       25",
"      </a>",
"      ]. The overall incidence per 10,000 population was estimated to be 1.28 in 2003, an increase from 0.91 in 2000. The authors noted that the most recent incidence rates exceed those of inflammatory bowel disease in children.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The majority of affected adults have been men in their 20s or 30s, although later presentations have been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/20,33\">",
"     20,33",
"    </a>",
"    ]. In a series of 31 adults (24 men and 7 women), the mean age at diagnosis was 34 years (range 14 to 77 years) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/33\">",
"     33",
"    </a>",
"    ]. Symptoms (predominantly dysphagia) had been present for an average of 4.5 years prior to diagnosis. The male predominance may be related to variations in a gene located on the X-chromosome that have been associated with eosinophilic esophagitis. (See",
"    <a class=\"local\" href=\"#H1536290\">",
"     'Pathogenesis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Among children, the disease is also more common in boys (71 percent in the series described above) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/25\">",
"     25",
"    </a>",
"    ]. In another population-based study, children with eosinophilic esophagitis were significantly more likely to be Caucasian (84 percent compared with 73 percent of the surrounding community as a whole) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/34\">",
"     34",
"    </a>",
"    ]. Patients were also more likely to be male (76 versus 48 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1536290\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of eosinophilic esophagitis is incompletely understood but includes environmental and genetic factors. Adaptive T-cell immunity driven by type 2 T-helper (Th2) cells, involving interleukin (IL)-13, IL-5, and IL-15 expression appears to play a major role in the pathogenesis of eosinophilic esophagitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/35-40\">",
"     35-40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41897?source=see_link\">",
"     \"T helper subsets: Differentiation and role in disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Eosinophils establish themselves as permanent residents of the gastrointestinal tract early during embryonic development, although they are not normally found in the esophagus. The process is regulated in part by the peptide eotaxin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/41\">",
"     41",
"    </a>",
"    ], which has a central role in antigen-mediated eosinophil recruitment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/42\">",
"     42",
"    </a>",
"    ]. The recruitment of eosinophils is observed in a variety of inflammatory or infectious conditions such as inflammatory bowel disease, gastroesophageal reflux, and exposure to food allergens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/43-45\">",
"     43-45",
"    </a>",
"    ]. Pathogenetic factors that distinguish eosinophilic esophagitis from other causes of esophageal eosinophilia are not yet certain but some studies suggest variations in molecular signatures. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Distinction from GERD'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1536312\">",
"    <span class=\"h2\">",
"     Environmental factors and T-cell immunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many patients with eosinophilic esophagitis have a history of allergies and peripheral eosinophilia (see",
"    <a class=\"local\" href=\"#H582285\">",
"     'Associations with other disorders'",
"    </a>",
"    below) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/5,46-49\">",
"     5,46-49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The association of eosinophilic esophagitis with allergies suggests that eosinophil recruitment to the esophagus may be an immune response to environmental antigens in genetically predisposed individuals. This hypothesis is supported by a few observations. First, feeding children with eosinophilic esophagitis an elemental diet (thus avoiding food allergens) results in clinical and histologic improvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/50\">",
"     50",
"    </a>",
"    ]. Second, a group has demonstrated that priming with epicutaneous exposure to antigens can result in esophageal eosinophil recruitment in a mouse model [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/51\">",
"     51",
"    </a>",
"    ]. Finally, there is seasonal variation in presentation, with fewer cases being diagnosed in the winter months (when outdoor aeroallergens are relatively low) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/31,52,53\">",
"     31,52,53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The immune response involves numerous cytokines, some of which have been implicated in the pathogenesis of eosinophilic esophagitis. Once in the esophagus, eosinophils appear capable of persistence through release of known eosinophil chemoattractants such as eotaxin, IL-3, IL-5, and granulocyte macrophage-colony stimulating factor (GM-CSF) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/54\">",
"     54",
"    </a>",
"    ]. The recognition of key modulators of eosinophil recruitment and function has important clinical implications. In addition to being potential targets for drug development, they may also have a role in the diagnosis and monitoring of the disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/55\">",
"     55",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/8/4231?source=see_link\">",
"     \"Role of cytokines in the immune system\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Studies of cytokines in eosinophilic esophagitis have shown the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      IL-5 and eotaxin &ndash; A murine model of eosinophilic esophagitis provided evidence that eotaxin and IL-5 play important roles in the pathogenesis of esophageal eosinophilia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/56\">",
"       56",
"      </a>",
"      ]. In the absence of eotaxin, eosinophil recruitment was attenuated, and in the absence of IL-5 it was ablated. Furthermore, mice engineered to be deficient in IL-5 were resistant to esophagitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/57\">",
"       57",
"      </a>",
"      ]. IL-5 appears to mediate eosinophil induced esophageal remodeling and collagen deposition [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/58\">",
"       58",
"      </a>",
"      ]. Other studies have demonstrated that the immunologic changes responsible for eosinophil recruitment in affected patients appear to be confined to the esophagus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/39\">",
"       39",
"      </a>",
"      ] and are driven mainly by an IL-5 selective Th2 response [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/59\">",
"       59",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      In another report, patients with eosinophilic esophagitis had a striking increase in expression of eotaxin-3 (also known as CCL26) and mice that were deficient in the eotaxin-3 receptor were protected from experimental eosinophilic esophagitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/60\">",
"       60",
"      </a>",
"      ]. In addition, another study demonstrated that treatment with topical glucocorticoids in patients with eosinophilic esophagitis down-regulated esophageal eotaxin-3 levels (as well as other cytokines implicated in eosinophilic esophagitis) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/61\">",
"       61",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      IL-13 &ndash; Intratracheal delivery of IL-13 induces esophageal eosinophilic inflammation by mechanisms that are dependent upon IL-5, eotaxin, and STAT6 (a signal transducer and activator of transcription) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/62\">",
"       62",
"      </a>",
"      ]. In addition, keratinocyte stimulation with IL-13 results in eotaxin-3 expression, a process that is reversible with glucocorticoids [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/63\">",
"       63",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      IL-15 &ndash; IL-15 activates T cells to produce cytokines that act on eosinophils. In a study of patients with eosinophilic esophagitis, IL-15 levels were increased sixfold in tissue samples and twofold in serum compared with controls [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Fibroblast growth factor 9 &ndash; Increased expression of fibroblast growth factor 9 (FGF9) and other profibrogenic cytokine genes (IL-5 and CCL18) in the subepithelial layer of the esophagus has been noted in eosinophilic esophagitis, suggesting that they may have a role in the fibrogenic response [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/64,65\">",
"       64,65",
"      </a>",
"      ]. Prolonged treatment with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/45/39632?source=see_link\">",
"       fluticasone",
"      </a>",
"      propionate has been associated with a downregulation of profibrogenic cytokine gene expression [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/65\">",
"       65",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Once in the esophagus, eosinophils may cause local inflammation by release of eosinophil major basic protein, a cytotoxic cationic protein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/66\">",
"     66",
"    </a>",
"    ]. The ongoing inflammatory response may be responsible for the development of dysphagia. A preliminary study suggested that the presence of intraepithelial eosinophils in the esophagus was associated with dysphagia, independent of the caliber of the esophageal lumen or the presence of a mechanical narrowing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/67\">",
"     67",
"    </a>",
"    ]. By contrast, dysphagia was associated with decreased esophageal distensibility that was not predicted by the eosinophil count in another report [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1536355\">",
"    <span class=\"h2\">",
"     Genetic factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;A genetic predisposition to eosinophilic esophagitis is supported by evidence of familial clustering. In addition, a possible susceptibility locus has been identified on chromosome 5q22 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A family history of eosinophilic esophagitis has been noted in some patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/25,26,70-72\">",
"     25,26,70-72",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of 103 children with eosinophilic esophagitis, a positive family history was observed in 7 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/25\">",
"       25",
"      </a>",
"      ]. This included three sibling pairs and the mother of one of the pairs of siblings. In addition, a family history of atopic disease was seen in 74 percent. (See",
"      <a class=\"local\" href=\"#H582285\">",
"       'Associations with other disorders'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      A case report documented three brothers with eosinophilic esophagitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/70\">",
"       70",
"      </a>",
"      ], while another documented an affected father and daughter [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/71\">",
"       71",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another report described 17 patients from seven families who had dysphagia and eosinophilia, although not all had eosinophilic esophagitis (some had Schatzki's ring while others had eosinophilic gastroenteritis) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/72\">",
"       72",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Clinical and pathological characteristics of patients with a familial form of eosinophilic esophagitis are similar to those with sporadic disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Genetic defects that may predispose to eosinophilic esophagitis have been identified. One study detected an eosinophilic esophagitis gene cluster that included a defect in filaggrin, a barrier protective molecule typically found in the skin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/36\">",
"     36",
"    </a>",
"    ]. Another genome wide study of children found an association of eosinophilic esophagitis with defects in thymic stromal lymphopoietin (TSLP, a cytokine involved in Th2 cell determination) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/69\">",
"     69",
"    </a>",
"    ]. Finally, a genetic variant of the TSLP receptor, which is encoded on a pseudoautosomal region of the X-chromosome, has been associated with eosinophilic esophagitis in male (but not female) patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of eosinophilic esophagitis vary with age. Adults and teenagers frequently present with dysphagia and food impactions, whereas in younger children symptoms often include feeding difficulties and abdominal pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H582018\">",
"    <span class=\"h2\">",
"     Clinical manifestations in adults",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common clinical manifestations seen in adults include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/7,20,24,31,75-100\">",
"     7,20,24,31,75-100",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Dysphagia",
"     </li>",
"     <li>",
"      Food impaction",
"     </li>",
"     <li>",
"      Chest pain that is often centrally located and does not respond to antacids",
"     </li>",
"     <li>",
"      Gastroesophageal reflux disease-like",
"      <span class=\"nowrap\">",
"       symptoms/refractory",
"      </span>",
"      heartburn",
"     </li>",
"     <li>",
"      Upper abdominal pain",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Dysphagia to solid foods is the most common symptom [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/7,75-79\">",
"     7,75-79",
"    </a>",
"    ]. Up to 15 percent of patients being evaluated for dysphagia with endoscopy are found to have eosinophilic esophagitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/77,79,101\">",
"     77,79,101",
"    </a>",
"    ]. A history of food impaction is present in up to 54 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/24,80,81\">",
"     24,80,81",
"    </a>",
"    ] and esophageal strictures have been noted in up to 31 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/31,82-87\">",
"     31,82-87",
"    </a>",
"    ]. In one community-based series, 17 of 31 patients presenting with food impaction over a three-year period were diagnosed with eosinophilic esophagitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Esophageal dysmotility may also be observed, suggesting possible involvement of the muscular layers of the esophagus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/88-90,102\">",
"     88-90,102",
"    </a>",
"    ]. High resolution endoscopic ultrasonography in affected children and adults has shown expansion of the esophageal wall and all individual tissue layers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/91-93\">",
"     91-93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Eosinophilic esophagitis has been noted in 1 to 4 percent of patients with refractory reflux in prospective studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/78,103\">",
"     78,103",
"    </a>",
"    ]. However, cost-effectiveness models suggest that evaluating for eosinophilic esophagitis in patients with refractory reflux is only cost-effective when the prevalence of eosinophilic esophagitis is greater than 8 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/104\">",
"     104",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Finally, spontaneous esophageal perforation (Boerhaave's syndrome), esophageal perforation following endoscopy, and mucosal tears associated with endoscopy have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/20,23,24,94-96\">",
"     20,23,24,94-96",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/58/29606?source=see_link\">",
"     \"Boerhaave's syndrome: Effort rupture of the esophagus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/57/10137?source=see_link&amp;anchor=H3#H3\">",
"     \"Complications of endoscopic esophageal stricture dilation\", section on 'Risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H582242\">",
"    <span class=\"h2\">",
"     Clinical manifestations in children",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms in children vary depending in part upon their age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/25,105-108\">",
"     25,105-108",
"    </a>",
"    ]. In one series, the most common presenting symptoms included [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/25\">",
"     25",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Feeding dysfunction (median age 2.0 years)",
"     </li>",
"     <li>",
"      Vomiting (median age 8.1 years)",
"     </li>",
"     <li>",
"      Abdominal pain (median age 12.0 years)",
"     </li>",
"     <li>",
"      Dysphagia (median age 13.4 years)",
"     </li>",
"     <li>",
"      Food impaction (median age 16.8 years)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The possibility of disease progression was supported in a case-control study that suggested an increased rate of dysphagia (49 versus 6 percent) and food impaction (40 versus 3 percent) in children with esophageal eosinophilia who had been followed for an average of 15 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/109\">",
"     109",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Feeding dysfunction continues to be defined, but is an increasingly recognized presentation of eosinophilic esophagitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/110\">",
"     110",
"    </a>",
"    ]. It includes failure to develop normal eating patterns (eg, not advancing past liquids) and adopting coping strategies (eg, refusing to eat solids after previously eating them).",
"   </p>",
"   <p>",
"    Similar findings were described in a single center report involving a total of 381 children. The mean age was 9 years and 66 percent were male. Patients most commonly presented with symptoms suggestive of gastroesophageal reflux (85 percent) or dysphagia (18 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/106\">",
"     106",
"    </a>",
"    ]. The esophageal mucosa was abnormal by endoscopy in 68 percent, whereas in 32 percent it appeared normal despite severe histologic eosinophilia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H582285\">",
"    <span class=\"h1\">",
"     ASSOCIATIONS WITH OTHER DISORDERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a strong association of eosinophilic esophagitis with allergic conditions such as food allergies, environmental allergies, asthma, and atopic dermatitis. It has been estimated that 28 to 86 percent of adults and 42 to 93 percent of children with eosinophilic esophagitis have another allergic disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/25,31,49,53,111-116\">",
"     25,31,49,53,111-116",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one series, 10 of 13 patients (77 percent) had a history of an allergic disorder defined as asthma, allergic rhinitis, urticaria, hay fever, atopic dermatitis, food allergy, or medicine allergy,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      positive radioallergosorbent test (RAST) or positive allergic skin tests [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/112\">",
"       112",
"      </a>",
"      ]. Twelve of 13 patients (92 percent) had an absolute peripheral eosinophilia and 9 of 12 patients (75 percent) had concurrent eosinophilic gastroenteritis.",
"     </li>",
"     <li>",
"      In another report, 13 of 19 children (68 percent) had positive skin or RAST testing to a median of seven foods [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/111\">",
"       111",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a third series, 18 of 23 adults (78 percent) had an atopic diathesis (most commonly allergic rhinitis) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/49\">",
"       49",
"      </a>",
"      ]. Most patients were sensitized to several environmental allergens. Among the foods tested, allergies to wheat, tomato, carrot, and onion were the most common.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An association with celiac disease (and response to a gluten free diet) was described in a case series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/117\">",
"     117",
"    </a>",
"    ]. In addition, an association with caustic injury, antibiotic exposure in infancy, and a Schatzki ring have also been described, although the strength of the associations is unclear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/118-122\">",
"     118-122",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of eosinophilic esophagitis should be based upon symptoms, endoscopic appearance, and histological findings. In patients suspected of having eosinophilic esophagitis, the first diagnostic test is typically an upper endoscopy with esophageal biopsies following one to two months of treatment with a proton pump inhibitor, though radiographic and laboratory findings may support the diagnosis. In addition, other disorders that can cause esophageal eosinophilia, such as gastroesophageal reflux disease (GERD), should be ruled out. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1679777\">",
"    <span class=\"h2\">",
"     Endoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of morphologic features in the esophagus have been described in patients with eosinophilic esophagitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/4,21,33,46,112,123-129\">",
"     4,21,33,46,112,123-129",
"    </a>",
"    ]. A 2012 meta-analysis that compared 4678 patients with eosinophilic esophagitis and 2742 controls estimated the frequency of the following endoscopic features [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/130\">",
"     130",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stacked circular rings (&ldquo;feline&rdquo; esophagus) (",
"      <a class=\"graphic graphic_picture graphicRef51432 \" href=\"mobipreview.htm?35/45/36575\">",
"       picture 1",
"      </a>",
"      ): 44 percent",
"     </li>",
"     <li>",
"      Strictures (particularly proximal strictures) (",
"      <a class=\"graphic graphic_picture graphicRef50566 \" href=\"mobipreview.htm?31/2/31791\">",
"       picture 2",
"      </a>",
"      ): 21 percent",
"     </li>",
"     <li>",
"      Attenuation of the subepithelial vascular pattern: 41 percent",
"     </li>",
"     <li>",
"      Linear furrows (",
"      <a class=\"graphic graphic_picture graphicRef74737 \" href=\"mobipreview.htm?22/23/22896\">",
"       picture 3",
"      </a>",
"      ): 48 percent",
"     </li>",
"     <li>",
"      Whitish papules (representing eosinophil microabscesses) (",
"      <a class=\"graphic graphic_picture graphicRef51432 \" href=\"mobipreview.htm?35/45/36575\">",
"       picture 1",
"      </a>",
"      ): 27 percent",
"     </li>",
"     <li>",
"      Small caliber esophagus: 9 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Individual endoscopic features suggestive of eosinophilic esophagitis had low sensitivity ranging from 15 to 48 percent but high specificity ranging from 90 to 95 percent. Positive and negative predictive values ranged from 51 to 73 percent and 74 to 83 percent, respectively. Given the low sensitivity of endoscopic findings for eosinophilic esophagitis and variable positive predictive value, histology remains important in making a diagnosis of eosinophilic esophagitis, regardless of the endoscopic appearance (see",
"    <a class=\"local\" href=\"#H1680258\">",
"     'Histology'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Complications associated with endoscopy in patients with eosinophilic esophagitis (even in the absence of esophageal dilation) include esophageal perforation and mucosal tears [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/23,94-96\">",
"     23,94-96",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1680258\">",
"    <span class=\"h2\">",
"     Histology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Esophageal biopsies from patients with eosinophilic esophagitis show an increased number of eosinophils. The vast majority of patients have at least 15 eosinophils per high power field (peak value) in at least one biopsy specimen after taking a proton pump inhibitor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/131\">",
"     131",
"    </a>",
"    ]. Esophageal eosinophilia in the absence of clinical features is not sufficient to make a diagnosis of eosinophilic esophagitis.",
"   </p>",
"   <p>",
"    During endoscopy biopsies should be obtained from the distal esophagus as well as either the mid or proximal esophagus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/132\">",
"     132",
"    </a>",
"    ]. The sensitivity of biopsies for diagnosing eosinophilic esophagitis depends upon the number of biopsies obtained:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a report of 66 adults, the sensitivity was 100 percent after obtaining five biopsies compared with 55 percent with one biopsy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/82\">",
"       82",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A second study found that the sensitivities for two, three, and six biopsies were 84, 97, and 100 percent, respectively [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/133\">",
"       133",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We suggest that, at a minimum, two to four biopsies be obtained from the distal esophagus, as well as another two to four from the mid or proximal esophagus.",
"   </p>",
"   <p>",
"    Biopsy specimens should be fixed in formalin or paraformaldehyde rather than Bouin's fixative since formalin is more effective at preserving the integrity of eosinophils. Immunohistochemical studies have demonstrated that the number of eosinophils and amount of degranulation are underestimated by standard (hematoxylin and eosin) staining, although the clinical relevance for making a diagnosis is unclear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/134\">",
"     134",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As noted above, a threshold of 15 eosinophils per high power (400x) field (HPF) is generally required for the diagnosis (",
"    <a class=\"graphic graphic_picture graphicRef70915 \" href=\"mobipreview.htm?31/10/31910\">",
"     picture 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/135\">",
"     135",
"    </a>",
"    ]. Biopsies should be obtained after one to two months of treatment with a proton pump inhibitor or a negative pH study. Acid suppression is critical since a subset of patients with large numbers of eosinophils may achieve complete histological resolution after treatment with a proton pump inhibitor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/136-138\">",
"     136-138",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other histologic findings suggestive of eosinophilic esophagitis include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/5,21,135,139-147\">",
"     5,21,135,139-147",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Eosinophil microabscesses",
"     </li>",
"     <li>",
"      Superficial layering of eosinophils",
"     </li>",
"     <li>",
"      Sheets of eosinophils",
"     </li>",
"     <li>",
"      Extracellular eosinophil granules",
"     </li>",
"     <li>",
"      Subepithelial and lamina propria fibrosis and inflammation",
"     </li>",
"     <li>",
"      Basal cell hyperplasia",
"     </li>",
"     <li>",
"      Papillary lengthening",
"     </li>",
"     <li>",
"      Increased numbers of mast cells, B cells, and IgE bearing cells",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While some studies suggest that histologic findings correlate with symptom severity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/7,148-150\">",
"     7,148-150",
"    </a>",
"    ], others do not [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/77,84,105,151\">",
"     77,84,105,151",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adults with symptoms suggestive of eosinophilic gastroenteritis (eg, abdominal pain, nausea, vomiting, diarrhea, ascites), as well as all children, should also have gastric and duodenal mucosal biopsies obtained, since the approach to patients with eosinophilic gastroenteritis varies from that for patients with eosinophilic esophagitis. However, at least one report found that a subset of patients has incidental gastric eosinophils, but a similar clinical presentation and response to treatment as patients without gastric involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/152\">",
"     152",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/43/43703?source=see_link\">",
"     \"Eosinophilic gastroenteritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18297054\">",
"    <span class=\"h2\">",
"     Radiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"     Barium",
"    </a>",
"    studies are not sensitive for diagnosing eosinophilic esophagitis, but can help characterize anatomic abnormalities and provide information on the length and diameter of strictures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/153\">",
"     153",
"    </a>",
"    ]. Findings described in patients with eosinophilic esophagitis undergoing barium studies include strictures and a ringed esophagus (",
"    <a class=\"graphic graphic_picture graphicRef73447 \" href=\"mobipreview.htm?32/27/33214\">",
"     picture 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/129\">",
"     129",
"    </a>",
"    ]. In addition, other causes for symptoms can be ruled out (ie, malrotation) as a cause for vomiting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18297061\">",
"    <span class=\"h2\">",
"     Laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no diagnostic serum markers for eosinophilic esophagitis. However, 50 to 60 percent of patients with eosinophilic esophagitis will have elevated serum IgE levels (&gt;114,000",
"    <span class=\"nowrap\">",
"     units/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/49,115\">",
"     49,115",
"    </a>",
"    ]. Peripheral eosinophilia is seen in 40 to 50 percent of patients but is generally mild [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/83,107,154,155\">",
"     83,107,154,155",
"    </a>",
"    ]. It decreases with topical glucocorticoid therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/156\">",
"     156",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1681291\">",
"    <span class=\"h2\">",
"     Evaluation for allergies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the strong association of eosinophilic esophagitis with allergies, we suggest that patients with eosinophilic esophagitis undergo evaluation by an allergist or immunologist. Children are often treated with dietary therapy and uncontrolled data suggest that the information gained from allergy testing may help guide therapy. In addition, dietary therapy is sometimes used in the treatment of motivated adults. Allergy testing may also help with the management of concomitant atopic disease, which is common in patients with eosinophilic esophagitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/16/44297?source=see_link&amp;anchor=H2895691#H2895691\">",
"     \"Treatment of eosinophilic esophagitis\", section on 'Dietary therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/55/32633?source=see_link\">",
"     \"Overview of skin testing for allergic disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/12/5321?source=see_link\">",
"     \"Diagnostic evaluation of food allergy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18301880\">",
"    <span class=\"h2\">",
"     Therapeutic trial",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with eosinophilic esophagitis should improve with appropriate therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/16/44297?source=see_link\">",
"     \"Treatment of eosinophilic esophagitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18302596\">",
"    <span class=\"h2\">",
"     Other diagnostic tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other diagnostic tests that have been evaluated but that are not routinely used include endoscopic ultrasound [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/157,158\">",
"     157,158",
"    </a>",
"    ], impedance planimetry to measure esophageal pressures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/68,159\">",
"     68,159",
"    </a>",
"    ], esophageal manometry [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/90,160,161\">",
"     90,160,161",
"    </a>",
"    ], and endoscopic confocal laser microscopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/162\">",
"     162",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Findings on standard esophageal manometry in patients with eosinophilic esophagitis are nonspecific.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis includes a variety of conditions that can cause morphologic or histologic findings that resemble eosinophilic esophagitis. These include gastroesophageal reflux disease (GERD), recurrent vomiting due to other causes, parasitic and fungal infections, congenital rings, Crohn's disease, periarteritis, allergic vasculitis, drug injury, connective tissue diseases, bullous pemphigoid, pemphigoid vegetans, graft versus host disease, achalasia, drug hypersensitivity, celiac disease, vasculitis, carcinoma, and a number of causes of peripheral eosinophilia in which the esophagus (along with other organ systems) may become involved. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/37/40535?source=see_link\">",
"     \"Diseases with eosinophilic involvement of specific organs\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are occasional patients who have characteristic findings of esophageal rings but do not have esophageal eosinophilia. In addition to considering the diagnoses above, it is important to ensure that adequate biopsies were obtained. In our clinical experience, some of these patients have responded to dietary elimination therapy used to treat eosinophilic esophagitis. Whether such patients have eosinophilia in deeper layers of the esophagus not sampled by standard biopsies is unknown.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Distinction from GERD",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common consideration in the differential diagnosis of eosinophilic esophagitis is GERD. As noted above, large numbers of eosinophils",
"    <span class=\"nowrap\">",
"     (&gt;100/HPF)",
"    </span>",
"    may be seen in association with GERD. (See",
"    <a class=\"local\" href=\"#H1680258\">",
"     'Histology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Case reports have described children with a dense eosinophilic infiltrate that resolved after treatment with a PPI alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/163\">",
"     163",
"    </a>",
"    ], suggesting that the histologic findings may have been due to GERD:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a series of 36 children with &ge;15",
"      <span class=\"nowrap\">",
"       eosinophils/HPF,",
"      </span>",
"      14 (39 percent) responded histologically to high-dose PPIs alone [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/140\">",
"       140",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study of 712 patients with upper gastrointestinal symptoms undergoing endoscopy, 35 (5 percent) had &ge;15",
"      <span class=\"nowrap\">",
"       eosinophils/HPF",
"      </span>",
"      on biopsies obtained from the upper-middle esophagus [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/164\">",
"       164",
"      </a>",
"      ]. Twenty-six patients (75 percent) had a clinicopathologic remission on treatment with a PPI, including half of the patients with a typical eosinophilic esophagitis phenotype. Based upon these findings, the authors concluded that using histologic criteria alone to diagnose eosinophilic esophagitis may lead to an overestimation of the prevalence of the disorder.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because of the association of GERD with esophageal eosinophilia, biopsies for eosinophilic esophagitis should be obtained after one to two months of treatment with a PPI or after an esophageal pH study has excluded reflux. In one study, 712 patients who were not on PPIs and were undergoing upper endoscopy for upper GI symptoms were examined [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/164\">",
"     164",
"    </a>",
"    ]. Thirty-five (5 percent) had &ge;15",
"    <span class=\"nowrap\">",
"     eosinophils/HPF",
"    </span>",
"    on initial examination. However, after treatment with a PPI, only 9 of the 35 (26 percent) met diagnostic criteria for eosinophilic esophagitis.",
"   </p>",
"   <p>",
"    A number of clinical and histologic features have been identified that may help distinguish eosinophilic esophagitis from GERD. Clinically, patients with eosinophilic esophagitis are more likely to be male and younger than 45 years of age. They are more likely to have dysphagia, esophageal morphological abnormalities (such as rings, furrows, or exudates), and food allergies, and are less likely to have a hiatal hernia or heartburn [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/83,165\">",
"     83,165",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Histologic features suggestive of eosinophilic esophagitis rather than GERD include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Large numbers of intraepithelial eosinophils on histologic examination [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/143,165-167\">",
"       143,165-167",
"      </a>",
"      ]. In two reports, the presence of more than 20",
"      <span class=\"nowrap\">",
"       eosinophils/HPF",
"      </span>",
"      was typically associated with non-acid-related causes of esophagitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/167\">",
"       167",
"      </a>",
"      ] and patients with eosinophilic esophagitis had significantly more eosinophils than patients who responded to therapy for GERD (28 to 31 versus 5 per HPF overall, and 19 to 32 versus 1 per HPF with biopsies from the proximal esophagus) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/166\">",
"       166",
"      </a>",
"      ]. Patients with eosinophilic esophagitis are also more likely to have &ge;15",
"      <span class=\"nowrap\">",
"       eosinophils/HPF",
"      </span>",
"      in three or more biopsies taken at different levels [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/140\">",
"       140",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Other histologic findings favoring eosinophilic esophagitis include proximal esophageal involvement, subepithelial and lamina propria fibrosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/142\">",
"       142",
"      </a>",
"      ], eosinophilic abscesses [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/107,165\">",
"       107,165",
"      </a>",
"      ], more severe basal cell hyperplasia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/168\">",
"       168",
"      </a>",
"      ], activated mucosal mast",
"      <span class=\"nowrap\">",
"       cells/increased",
"      </span>",
"      epithelial tryptase density [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/144,147,169,170\">",
"       144,147,169,170",
"      </a>",
"      ], and degranulating eosinophils [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/83\">",
"       83",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Assessment of eotaxin-3 and major basic protein (MBP) levels in esophageal biopsy specimens (by immunohistochemistry or real-time PCR) has been suggested to help differentiate GERD from eosinophilic esophagitis, but further studies are needed [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/143,171,172\">",
"       143,171,172",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H1536312\">",
"       'Environmental factors and T-cell immunity'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18301888\">",
"    <span class=\"h2\">",
"     Proton pump inhibitor-responsive esophageal eosinophilia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increasingly, it is being recognized that there is a group of patients who have typical symptoms of eosinophilic esophagitis and have had GERD diagnostically excluded, but who have a clinical and histologic response to proton pump inhibitors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/45/32474/abstract/140,148,173-177\">",
"     140,148,173-177",
"    </a>",
"    ]. The mechanisms involved in such a response are not well understood.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/41/33426?source=see_link\">",
"       \"Patient information: Upper endoscopy (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?38/54/39778?source=see_link\">",
"       \"Patient information: Eosinophilic esophagitis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?21/0/21506?source=see_link\">",
"       \"Patient information: Upper endoscopy (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Eosinophilic esophagitis should be considered in adults with a history of food impaction, with persistent dysphagia, or with gastroesophageal reflux disease (GERD) that fails to respond to medical therapy. In children, symptoms that may be associated with eosinophilic esophagitis vary by age and include feeding disorders, vomiting, abdominal pain, dysphagia, and food impaction. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      In particular, the diagnosis should be considered in young men or boys, and in those with a history of food or environmental allergies, asthma, or atopy. A history of esophageal perforation or severe pain after dilation of a stricture should also raise suspicion of this disorder.",
"     </li>",
"     <li>",
"      Making a diagnosis of eosinophilic esophagitis requires the presence of both symptoms and histologic findings. In addition, other disorders that can cause esophageal eosinophilia, such as GERD, should be ruled out. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients suspected of having eosinophilic esophagitis, the first diagnostic test is typically an upper endoscopy with esophageal biopsies, though radiographic and laboratory findings may support the diagnosis. We suggest that, at a minimum, two to four biopsies be obtained from the distal esophagus, as well as another two to four from the mid or proximal esophagus. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A variety of morphologic features in the esophagus have been described in patients with eosinophilic esophagitis. Endoscopic findings include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Stacked circular rings (\"feline\" esophagus) (",
"      <a class=\"graphic graphic_picture graphicRef51432 \" href=\"mobipreview.htm?35/45/36575\">",
"       picture 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Strictures (particularly proximal strictures) (",
"      <a class=\"graphic graphic_picture graphicRef50566 \" href=\"mobipreview.htm?31/2/31791\">",
"       picture 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Attenuation of the subepithelial vascular pattern",
"     </li>",
"     <li>",
"      Linear furrowing that may extend the entire length of the esophagus (",
"      <a class=\"graphic graphic_picture graphicRef74737 \" href=\"mobipreview.htm?22/23/22896\">",
"       picture 3",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Whitish papules (representing eosinophil microabscesses) (",
"      <a class=\"graphic graphic_picture graphicRef51432 \" href=\"mobipreview.htm?35/45/36575\">",
"       picture 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Small caliber esophagus",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Histologic findings suggestive of eosinophilic esophagitis include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Peak eosinophil count of &ge;15 eosinophils per high powered (400x) field (",
"      <a class=\"graphic graphic_picture graphicRef70915 \" href=\"mobipreview.htm?31/10/31910\">",
"       picture 4",
"      </a>",
"      ) despite acid suppression with a PPI for one to two months or a negative pH study",
"     </li>",
"     <li>",
"      Eosinophil microabscesses",
"     </li>",
"     <li>",
"      Superficial layering of eosinophils",
"     </li>",
"     <li>",
"      Sheets of eosinophils",
"     </li>",
"     <li>",
"      Extracellular eosinophil granules",
"     </li>",
"     <li>",
"      Subepithelial and lamina propria fibrosis and inflammation",
"     </li>",
"     <li>",
"      Basal cell hyperplasia",
"     </li>",
"     <li>",
"      Papillary lengthening",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Because of the strong association of eosinophilic esophagitis with allergies, we suggest that patients with eosinophilic esophagitis undergo evaluation by an allergist or immunologist. In children the results of the evaluation may have treatment implications (eg, elimination diets) though in adults the results usually do not influence the initial treatment decisions. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/55/32633?source=see_link\">",
"       \"Overview of skin testing for allergic disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/12/5321?source=see_link\">",
"       \"Diagnostic evaluation of food allergy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"./dietary-management-of-eosinophilic-esophagitis?source=see_link&amp;anchor=H9242303#H9242303\">",
"       \"Dietary management of eosinophilic esophagitis\", section on 'Elimination diets'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/1\">",
"      Winter HS, Madara JL, Stafford RJ, et al. Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology 1982; 83:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/2\">",
"      Furuta GT. Eosinophils in the esophagus: acid is not the only cause. J Pediatr Gastroenterol Nutr 1998; 26:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/3\">",
"      Ahmad M, Soetikno RM, Ahmed A. The differential diagnosis of eosinophilic esophagitis. J Clin Gastroenterol 2000; 30:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/4\">",
"      MacCarty RL, Talley NJ. Barium studies in diffuse eosinophilic gastroenteritis. Gastrointest Radiol 1990; 15:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/5\">",
"      Dobbins JW, Sheahan DG, Behar J. Eosinophilic gastroenteritis with esophageal involvement. Gastroenterology 1977; 72:1312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/6\">",
"      Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/7\">",
"      Kapel RC, Miller JK, Torres C, et al. Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups. Gastroenterology 2008; 134:1316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/8\">",
"      Spergel JM, Book WM, Mays E, et al. Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr 2011; 52:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/9\">",
"      Hurrell JM, Genta RM, Dellon ES. Prevalence of esophageal eosinophilia varies by climate zone in the United States. Am J Gastroenterol 2012; 107:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/10\">",
"      Kelley ML Jr, Frazer JP. Symptomatic mid-esophageal webs. JAMA 1966; 197:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/11\">",
"      Landres RT, Kuster GG, Strum WB. Eosinophilic esophagitis in a patient with vigorous achalasia. Gastroenterology 1978; 74:1298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/12\">",
"      Shiflett DW, Gilliam JH, Wu WC, et al. Multiple esophageal webs. Gastroenterology 1979; 77:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/13\">",
"      Bousvaros A, Antonioli DA, Winter HS. Ringed esophagus: an association with esophagitis. Am J Gastroenterol 1992; 87:1187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/14\">",
"      McKinley MJ, Eisner TD, Fisher ML, et al. Multiple rings of the esophagus associated with gastroesophageal reflux [case report]. Am J Gastroenterol 1996; 91:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/15\">",
"      Langdon DE. Corrugated ringed and too small esophagi. Am J Gastroenterol 1999; 94:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/16\">",
"      Langdon DE. Corrugated ringed esophagus. Am J Gastroenterol 1993; 88:1461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/17\">",
"      Katzka DA, Levine MS, Ginsberg GG, et al. Congenital esophageal stenosis in adults. Am J Gastroenterol 2000; 95:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/18\">",
"      Morrow JB, Vargo JJ, Goldblum JR, Richter JE. The ringed esophagus: histological features of GERD. Am J Gastroenterol 2001; 96:984.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/19\">",
"      Gluck M, Schembre D, Jiranek G. Multiple esophageal rings: Histology, EUS, and manometric findings (abstract). Am J Gastroenterol 2001; 96:S14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/20\">",
"      Straumann A, Rossi L, Simon HU, et al. Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Gastrointest Endosc 2003; 57:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/21\">",
"      Losurdo J, Bruninga K, Dobozi B. Idiopathic eosinophilic esophagitis: A new cause of \"feline\" esophagus (abstract). Gastroenterology 1999; 116:A239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/22\">",
"      Vasilopoulos S, Murphy P, Auerbach A, et al. The small-caliber esophagus: an unappreciated cause of dysphagia for solids in patients with eosinophilic esophagitis. Gastrointest Endosc 2002; 55:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/23\">",
"      Cohen MS, Kaufman AB, Palazzo JP, et al. An audit of endoscopic complications in adult eosinophilic esophagitis. Clin Gastroenterol Hepatol 2007; 5:1149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/24\">",
"      Straumann A, Bussmann C, Zuber M, et al. Eosinophilic esophagitis: analysis of food impaction and perforation in 251 adolescent and adult patients. Clin Gastroenterol Hepatol 2008; 6:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/25\">",
"      Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med 2004; 351:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/26\">",
"      Straumann A, Simon HU. Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol 2005; 115:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/27\">",
"      Erwin EA, Asti L, Hemming T, Kelleher KJ. A decade of hospital discharges related to eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2012; 54:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/28\">",
"      Soon IS, Butzner JD, Kaplan GG, Debruyn JC. Incidence and Prevalence of Eosinophilic Esophagitis in Children: Systematic Review and Meta-Analysis. J Pediatr Gastroenterol Nutr 2013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/29\">",
"      Lee JJ, Baker RD, Khan AR, Baker SS. Childhood esophagitis: then and now. J Pediatr Gastroenterol Nutr 2009; 48:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/30\">",
"      Vanderheyden AD, Petras RE, DeYoung BR, Mitros FA. Emerging eosinophilic (allergic) esophagitis: increased incidence or increased recognition? Arch Pathol Lab Med 2007; 131:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/31\">",
"      Prasad GA, Alexander JA, Schleck CD, et al. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol 2009; 7:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/32\">",
"      Hruz P, Straumann A, Bussmann C, et al. Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. J Allergy Clin Immunol 2011; 128:1349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/33\">",
"      Croese J, Fairley SK, Masson JW, et al. Clinical and endoscopic features of eosinophilic esophagitis in adults. Gastrointest Endosc 2003; 58:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/34\">",
"      Franciosi JP, Tam V, Liacouras CA, Spergel JM. A case-control study of sociodemographic and geographic characteristics of 335 children with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2009; 7:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/35\">",
"      Rothenberg ME. Biology and treatment of eosinophilic esophagitis. Gastroenterology 2009; 137:1238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/36\">",
"      Blanchard C, Stucke EM, Burwinkel K, et al. Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol 2010; 184:4033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/37\">",
"      Zuo L, Fulkerson PC, Finkelman FD, et al. IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway. J Immunol 2010; 185:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/38\">",
"      Zhu X, Wang M, Mavi P, et al. Interleukin-15 expression is increased in human eosinophilic esophagitis and mediates pathogenesis in mice. Gastroenterology 2010; 139:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/39\">",
"      Straumann A, Bauer M, Fischer B, et al. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol 2001; 108:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/40\">",
"      Furuta GT, Straumann A. Review article: the pathogenesis and management of eosinophilic oesophagitis. Aliment Pharmacol Ther 2006; 24:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/41\">",
"      Mishra A, Hogan SP, Lee JJ, et al. Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest 1999; 103:1719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/42\">",
"      Hogan SP, Mishra A, Brandt EB, et al. A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy. Proc Natl Acad Sci U S A 2000; 97:6681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/43\">",
"      Winterkamp S, Raithel M, Hahn EG. Secretion and tissue content of eosinophil cationic protein in Crohn's disease. J Clin Gastroenterol 2000; 30:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/44\">",
"      Matsumoto T, Goto Y, Miike T. Markedly high eosinophilia and an elevated serum IL-5 level in an infant with cow milk allergy. Ann Allergy Asthma Immunol 1999; 82:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/45\">",
"      Levy AM, Kita H, Phillips SF, et al. Eosinophilia and gastrointestinal symptoms after ingestion of shiitake mushrooms. J Allergy Clin Immunol 1998; 101:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/46\">",
"      Picus D, Frank PH. Eosinophilic esophagitis. AJR Am J Roentgenol 1981; 136:1001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/47\">",
"      Khan S, Orenstein SR, Di Lorenzo C, et al. Eosinophilic esophagitis: strictures, impactions, dysphagia. Dig Dis Sci 2003; 48:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/48\">",
"      Sant'Anna AM, Rolland S, Fournet JC, et al. Eosinophilic esophagitis in children: symptoms, histology and pH probe results. J Pediatr Gastroenterol Nutr 2004; 39:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/49\">",
"      Roy-Ghanta S, Larosa DF, Katzka DA. Atopic characteristics of adult patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2008; 6:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/50\">",
"      Kelly KJ, Lazenby AJ, Rowe PC, et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 1995; 109:1503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/51\">",
"      Akei HS, Mishra A, Blanchard C, Rothenberg ME. Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology 2005; 129:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/52\">",
"      Wang FY, Gupta SK, Fitzgerald JF. Is there a seasonal variation in the incidence or intensity of allergic eosinophilic esophagitis in newly diagnosed children? J Clin Gastroenterol 2007; 41:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/53\">",
"      Almansa C, Krishna M, Buchner AM, et al. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol 2009; 104:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/54\">",
"      Desreumaux P, Bloget F, Seguy D, et al. Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis. Gastroenterology 1996; 110:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/55\">",
"      Konikoff MR, Blanchard C, Kirby C, et al. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis. Clin Gastroenterol Hepatol 2006; 4:1328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/56\">",
"      Mishra A, Hogan SP, Brandt EB, Rothenberg ME. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest 2001; 107:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/57\">",
"      Mishra A, Hogan SP, Brandt EB, Rothenberg ME. IL-5 promotes eosinophil trafficking to the esophagus. J Immunol 2002; 168:2464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/58\">",
"      Mishra A, Wang M, Pemmaraju VR, et al. Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology 2008; 134:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/59\">",
"      Gupta SK, Fitzgerald JF, Kondratyuk T, HogenEsch H. Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2006; 42:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/60\">",
"      Blanchard C, Wang N, Stringer KF, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006; 116:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/61\">",
"      Lucendo AJ, De Rezende L, Comas C, et al. Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis. Am J Gastroenterol 2008; 103:2184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/62\">",
"      Mishra A, Rothenberg ME. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology 2003; 125:1419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/63\">",
"      Blanchard C, Mingler MK, Vicario M, et al. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol 2007; 120:1292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/64\">",
"      Mulder DJ, Pacheco I, Hurlbut DJ, et al. FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis. Gut 2009; 58:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/65\">",
"      Lucendo AJ, Arias A, De Rezende LC, et al. Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study. J Allergy Clin Immunol 2011; 128:1037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/66\">",
"      Talley NJ, Kephart GM, McGovern TW, et al. Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease. Gastroenterology 1992; 103:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/67\">",
"      Awad ZT, Watson P, Smyrk T. Dysphagia is associated with intraepithelial eosinophils (IEE) in esophageal biopsies (abstract). Gastroenterology 2000; 118 (Suppl 2):A243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/68\">",
"      Kwiatek MA, Hirano I, Kahrilas PJ, et al. Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology 2011; 140:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/69\">",
"      Rothenberg ME, Spergel JM, Sherrill JD, et al. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet 2010; 42:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/70\">",
"      Patel SM, Falchuk KR. Three brothers with dysphagia caused by eosinophilic esophagitis. Gastrointest Endosc 2005; 61:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/71\">",
"      Meyer GW. Eosinophilic esophagitis in a father and a daughter. Gastrointest Endosc 2005; 61:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/72\">",
"      Zink DA, Amin M, Gebara S, Desai TK. Familial dysphagia and eosinophilia. Gastrointest Endosc 2007; 65:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/73\">",
"      Collins MH, Blanchard C, Abonia JP, et al. Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases. Clin Gastroenterol Hepatol 2008; 6:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/74\">",
"      Sherrill JD, Gao PS, Stucke EM, et al. Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. J Allergy Clin Immunol 2010; 126:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/75\">",
"      Sgouros SN, Bergele C, Mantides A. Eosinophilic esophagitis in adults: a systematic review. Eur J Gastroenterol Hepatol 2006; 18:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/76\">",
"      Pasha SF, DiBaise JK, Kim HJ, et al. Patient characteristics, clinical, endoscopic, and histologic findings in adult eosinophilic esophagitis: a case series and systematic review of the medical literature. Dis Esophagus 2007; 20:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/77\">",
"      Prasad GA, Talley NJ, Romero Y, et al. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol 2007; 102:2627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/78\">",
"      Garc&iacute;a-Compe&aacute;n D, Gonz&aacute;lez Gonz&aacute;lez JA, Marrufo Garc&iacute;a CA, et al. Prevalence of eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease symptoms: A prospective study. Dig Liver Dis 2011; 43:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/79\">",
"      Mackenzie SH, Go M, Chadwick B, et al. Eosinophilic oesophagitis in patients presenting with dysphagia--a prospective analysis. Aliment Pharmacol Ther 2008; 28:1140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/80\">",
"      Desai TK, Stecevic V, Chang CH, et al. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc 2005; 61:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/81\">",
"      Remedios M, Campbell C, Jones DM, Kerlin P. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc 2006; 63:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/82\">",
"      Gonsalves N, Policarpio-Nicolas M, Zhang Q, et al. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc 2006; 64:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/83\">",
"      Dellon ES, Gibbs WB, Fritchie KJ, et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2009; 7:1305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/84\">",
"      Schoepfer AM, Gonsalves N, Bussmann C, et al. Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation. Am J Gastroenterol 2010; 105:1062.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/85\">",
"      Bohm M, Richter JE, Kelsen S, Thomas R. Esophageal dilation: simple and effective treatment for adults with eosinophilic esophagitis and esophageal rings and narrowing. Dis Esophagus 2010; 23:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/86\">",
"      Kanakala V, Lamb CA, Haigh C, et al. The diagnosis of primary eosinophilic oesophagitis in adults: missed or misinterpreted? Eur J Gastroenterol Hepatol 2010; 22:848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/87\">",
"      Lucendo AJ, De Rezende L. Endoscopic dilation in eosinophilic esophagitis: a treatment strategy associated with a high risk of perforation. Endoscopy 2007; 39:376; author reply 377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/88\">",
"      Matzinger MA, Daneman A. Esophageal involvement in eosinophilic gastroenteritis. Pediatr Radiol 1983; 13:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/89\">",
"      Lucendo AJ, Castillo P, Mart&iacute;n-Ch&aacute;varri S, et al. Manometric findings in adult eosinophilic oesophagitis: a study of 12 cases. Eur J Gastroenterol Hepatol 2007; 19:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/90\">",
"      Nurko S, Rosen R, Furuta GT. Esophageal dysmotility in children with eosinophilic esophagitis: a study using prolonged esophageal manometry. Am J Gastroenterol 2009; 104:3050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/91\">",
"      Fox VL, Nurko S, Teitelbaum JE, et al. High-resolution EUS in children with eosinophilic \"allergic\" esophagitis. Gastrointest Endosc 2003; 57:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/92\">",
"      Bhutani MS, Moparty B, Chaya CT, et al. Endoscopic ultrasound-guided fine-needle aspiration of enlarged mediastinal lymph nodes in eosinophilic esophagitis. Endoscopy 2007; 39 Suppl 1:E82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/93\">",
"      Furuta K, Adachi K, Kowari K, et al. A Japanese case of eosinophilic esophagitis. J Gastroenterol 2006; 41:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/94\">",
"      Kaplan M, Mutlu EA, Jakate S, et al. Endoscopy in eosinophilic esophagitis: \"feline\" esophagus and perforation risk. Clin Gastroenterol Hepatol 2003; 1:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/95\">",
"      Shim LS, Grehan M. Education and Imaging. Gastrointestinal: oesophageal perforation during endoscopy for food impaction in eosinophilic oesophagitis. J Gastroenterol Hepatol 2010; 25:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/96\">",
"      Nantes O, Jim&eacute;nez FJ, Zozaya JM, Vila JJ. Increased risk of esophageal perforation in eosinophilic esophagitis. Endoscopy 2009; 41 Suppl 2:E177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/97\">",
"      Achem SR, Almansa C, Krishna M, et al. Oesophageal eosinophilic infiltration in patients with noncardiac chest pain. Aliment Pharmacol Ther 2011; 33:1194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/98\">",
"      Sperry SL, Crockett SD, Miller CB, et al. Esophageal foreign-body impactions: epidemiology, time trends, and the impact of the increasing prevalence of eosinophilic esophagitis. Gastrointest Endosc 2011; 74:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/99\">",
"      Menard-Katcher P, Marks KL, Liacouras CA, et al. The natural history of eosinophilic oesophagitis in the transition from childhood to adulthood. Aliment Pharmacol Ther 2013; 37:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/100\">",
"      Mahesh VN, Holloway RH, Nguyen NQ. Changing epidemiology of food bolus impaction: Is eosinophilic esophagitis to blame? J Gastroenterol Hepatol 2013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/101\">",
"      Kidambi T, Toto E, Ho N, et al. Temporal trends in the relative prevalence of dysphagia etiologies from 1999-2009. World J Gastroenterol 2012; 18:4335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/102\">",
"      Melchior C, Chiavelli H, Leroi AM, et al. Recovery of a \"Jackhammer esophagus\" after the treatment of an eosinophilic esophagitis. Am J Gastroenterol 2012; 107:952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/103\">",
"      S&aacute; CC, Kishi HS, Silva-Werneck AL, et al. Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor. Clinics (Sao Paulo) 2011; 66:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/104\">",
"      Miller SM, Goldstein JL, Gerson LB. Cost-effectiveness model of endoscopic biopsy for eosinophilic esophagitis in patients with refractory GERD. Am J Gastroenterol 2011; 106:1439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/105\">",
"      Baxi S, Gupta SK, Swigonski N, Fitzgerald JF. Clinical presentation of patients with eosinophilic inflammation of the esophagus. Gastrointest Endosc 2006; 64:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/106\">",
"      Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 2005; 3:1198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/107\">",
"      Aceves SS, Newbury RO, Dohil R, et al. Distinguishing eosinophilic esophagitis in pediatric patients: clinical, endoscopic, and histologic features of an emerging disorder. J Clin Gastroenterol 2007; 41:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/108\">",
"      Gill R, Durst P, Rewalt M, Elitsur Y. Eosinophilic esophagitis disease in children from West Virginia: a review of the last decade (1995-2004). Am J Gastroenterol 2007; 102:2281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/109\">",
"      DeBrosse CW, Franciosi JP, King EC, et al. Long-term outcomes in pediatric-onset esophageal eosinophilia. J Allergy Clin Immunol 2011; 128:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/110\">",
"      Mukkada VA, Haas A, Maune NC, et al. Feeding dysfunction in children with eosinophilic gastrointestinal diseases. Pediatrics 2010; 126:e672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/111\">",
"      Orenstein SR, Shalaby TM, Di Lorenzo C, et al. The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children. Am J Gastroenterol 2000; 95:1422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/112\">",
"      Vitellas KM, Bennett WF, Bova JG, et al. Idiopathic eosinophilic esophagitis. Radiology 1993; 186:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/113\">",
"      Moawad FJ, Veerappan GR, Lake JM, et al. Correlation between eosinophilic oesophagitis and aeroallergens. Aliment Pharmacol Ther 2010; 31:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/114\">",
"      Spergel JM, Brown-Whitehorn TF, Beausoleil JL, et al. 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr 2009; 48:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/115\">",
"      Erwin EA, James HR, Gutekunst HM, et al. Serum IgE measurement and detection of food allergy in pediatric patients with eosinophilic esophagitis. Ann Allergy Asthma Immunol 2010; 104:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/116\">",
"      Dohil R, Newbury R, Fox L, et al. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology 2010; 139:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/117\">",
"      Quaglietta L, Coccorullo P, Miele E, et al. Eosinophilic oesophagitis and coeliac disease: is there an association? Aliment Pharmacol Ther 2007; 26:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/118\">",
"      Nurko S, Teitelbaum JE, Husain K, et al. Association of Schatzki ring with eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr 2004; 38:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/119\">",
"      Sgouros SN, Bergele C, Mantides A. Schatzki's rings are not associated with eosinophilic esophagitis. Gastrointest Endosc 2006; 63:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/120\">",
"      Desai, T, Furuta, GT. Response. Gastrointest Endosc 2006; 63:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/121\">",
"      Homan M, Orel R, Liacouras C. Caustic ingestion: a possible cause of eosinophilic esophagitis? Pediatrics 2013; 131:e1284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/122\">",
"      Jensen ET, Kappelman MD, Kim HP, et al. Early Life Exposures as Risk Factors Forpediatric Eosinophilic Esophagitis: A Pilot and Feasibility Study. J Pediatr Gastroenterol Nutr 2013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/123\">",
"      Liacouras CA, Wenner WJ, Brown K, Ruchelli E. Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr 1998; 26:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/124\">",
"      Siafakas CG, Ryan CK, Brown MR, Miller TL. Multiple esophageal rings: an association with eosinophilic esophagitis: case report and review of the literature. Am J Gastroenterol 2000; 95:1572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/125\">",
"      Feczko PJ, Halpert RD, Zonca M. Radiographic abnormalities in eosinophilic esophagitis. Gastrointest Radiol 1985; 10:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/126\">",
"      Potter JW, Saeian K, Staff D, et al. Eosinophilic esophagitis in adults: an emerging problem with unique esophageal features. Gastrointest Endosc 2004; 59:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/127\">",
"      Noel RJ, Putnam PE, Collins MH, et al. Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol 2004; 2:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/128\">",
"      Lim JR, Gupta SK, Croffie JM, et al. White specks in the esophageal mucosa: An endoscopic manifestation of non-reflux eosinophilic esophagitis in children. Gastrointest Endosc 2004; 59:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/129\">",
"      Zimmerman SL, Levine MS, Rubesin SE, et al. Idiopathic eosinophilic esophagitis in adults: the ringed esophagus. Radiology 2005; 236:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/130\">",
"      Kim HP, Vance RB, Shaheen NJ, Dellon ES. The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/131\">",
"      Ravi K, Talley NJ, Smyrk TC, et al. Low grade esophageal eosinophilia in adults: an unrecognized part of the spectrum of eosinophilic esophagitis? Dig Dis Sci 2011; 56:1981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/132\">",
"      Collins MH. Histopathologic features of eosinophilic esophagitis. Gastrointest Endosc Clin N Am 2008; 18:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/133\">",
"      Shah A, Kagalwalla AF, Gonsalves N, et al. Histopathologic variability in children with eosinophilic esophagitis. Am J Gastroenterol 2009; 104:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/134\">",
"      Mueller S, Aigner T, Neureiter D, Stolte M. Eosinophil infiltration and degranulation in oesophageal mucosa from adult patients with eosinophilic oesophagitis: a retrospective and comparative study on pathological biopsy. J Clin Pathol 2006; 59:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/135\">",
"      Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007; 133:1342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/136\">",
"      Rodrigo S, Abboud G, Oh D, et al. High intraepithelial eosinophil counts in esophageal squamous epithelium are not specific for eosinophilic esophagitis in adults. Am J Gastroenterol 2008; 103:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/137\">",
"      Odze RD. Pathology of eosinophilic esophagitis: what the clinician needs to know. Am J Gastroenterol 2009; 104:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/138\">",
"      Dubecz A, Mentrikoski M, Peters JH. Eosinophilic esophagitis with severe GERD. Am J Gastroenterol 2009; 104:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/139\">",
"      Genta RM, Spechler SJ, Souza RF. The Twentieth Eosinophil. Adv Anat Pathol 2007; 14:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/140\">",
"      Sayej WN, Patel R, Baker RD, et al. Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2009; 49:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/141\">",
"      Chehade M, Sampson HA, Morotti RA, Magid MS. Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2007; 45:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/142\">",
"      Lee S, de Boer WB, Naran A, et al. More than just counting eosinophils: proximal oesophageal involvement and subepithelial sclerosis are major diagnostic criteria for eosinophilic oesophagitis. J Clin Pathol 2010; 63:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/143\">",
"      Protheroe C, Woodruff SA, de Petris G, et al. A novel histologic scoring system to evaluate mucosal biopsies from patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2009; 7:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/144\">",
"      Kirsch R, Bokhary R, Marcon MA, Cutz E. Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2007; 44:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/145\">",
"      Vicario M, Blanchard C, Stringer KF, et al. Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis. Gut 2010; 59:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/146\">",
"      Mueller S, Neureiter D, Aigner T, Stolte M. Comparison of histological parameters for the diagnosis of eosinophilic oesophagitis versus gastro-oesophageal reflux disease on oesophageal biopsy material. Histopathology 2008; 53:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/147\">",
"      Dellon ES, Chen X, Miller CR, et al. Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease. Am J Gastroenterol 2011; 106:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/148\">",
"      Peterson KA, Thomas KL, Hilden K, et al. Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci 2010; 55:1313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/149\">",
"      Aceves SS, Ackerman SJ. Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis. Immunol Allergy Clin North Am 2009; 29:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/150\">",
"      Aceves SS, Newbury RO, Chen D, et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy 2010; 65:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/151\">",
"      Pentiuk S, Putnam PE, Collins MH, Rothenberg ME. Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2009; 48:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/152\">",
"      Ammoury RF, Rosenman MB, Roettcher D, Gupta SK. Incidental gastric eosinophils in patients with eosinophilic esophagitis: do they matter? J Pediatr Gastroenterol Nutr 2010; 51:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/153\">",
"      Binkovitz LA, Lorenz EA, Di Lorenzo C, Kahwash S. Pediatric eosinophilic esophagitis: radiologic findings with pathologic correlation. Pediatr Radiol 2010; 40:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/154\">",
"      Dellon ES, Aderoju A, Woosley JT, et al. Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol 2007; 102:2300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/155\">",
"      Chehade M, Sampson HA. Epidemiology and etiology of eosinophilic esophagitis. Gastrointest Endosc Clin N Am 2008; 18:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/156\">",
"      Straumann A, Conus S, Degen L, et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology 2010; 139:1526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/157\">",
"      Dalby K, Nielsen RG, Kruse-Andersen S, et al. Gastroesophageal reflux disease and eosinophilic esophagitis in infants and children. A study of esophageal pH, multiple intraluminal impedance and endoscopic ultrasound. Scand J Gastroenterol 2010; 45:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/158\">",
"      Korsapati H, Babaei A, Bhargava V, et al. Dysfunction of the longitudinal muscles of the oesophagus in eosinophilic oesophagitis. Gut 2009; 58:1056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/159\">",
"      Roman S, Hirano I, Kwiatek MA, et al. Manometric features of eosinophilic esophagitis in esophageal pressure topography. Neurogastroenterol Motil 2011; 23:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/160\">",
"      Mart&iacute;n Mart&iacute;n L, Santander C, Lopez Mart&iacute;n MC, et al. Esophageal motor abnormalities in eosinophilic esophagitis identified by high-resolution manometry. J Gastroenterol Hepatol 2011; 26:1447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/161\">",
"      Moawad FJ, Maydonovitch CL, Veerappan GR, et al. Esophageal motor disorders in adults with eosinophilic esophagitis. Dig Dis Sci 2011; 56:1427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/162\">",
"      Rogart JN, Nagata J, Loeser CS, et al. Multiphoton imaging can be used for microscopic examination of intact human gastrointestinal mucosa ex vivo. Clin Gastroenterol Hepatol 2008; 6:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/163\">",
"      Ngo P, Furuta GT, Antonioli DA, Fox VL. Eosinophils in the esophagus--peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol 2006; 101:1666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/164\">",
"      Molina-Infante J, Ferrando-Lamana L, Ripoll C, et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol 2011; 9:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/165\">",
"      Parfitt JR, Gregor JC, Suskin NG, et al. Eosinophilic esophagitis in adults: distinguishing features from gastroesophageal reflux disease: a study of 41 patients. Mod Pathol 2006; 19:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/166\">",
"      Walsh SV, Antonioli DA, Goldman H, et al. Allergic esophagitis in children: a clinicopathological entity. Am J Surg Pathol 1999; 23:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/167\">",
"      Steiner SJ, Gupta SK, Croffie JM, Fitzgerald JF. Correlation between number of eosinophils and reflux index on same day esophageal biopsy and 24 hour esophageal pH monitoring. Am J Gastroenterol 2004; 99:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/168\">",
"      Steiner SJ, Kernek KM, Fitzgerald JF. Severity of basal cell hyperplasia differs in reflux versus eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2006; 42:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/169\">",
"      Abonia JP, Blanchard C, Butz BB, et al. Involvement of mast cells in eosinophilic esophagitis. J Allergy Clin Immunol 2010; 126:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/170\">",
"      Sridhara S, Ravi K, Smyrk TC, et al. Increased numbers of eosinophils, rather than only etiology, predict histologic changes in patients with esophageal eosinophilia. Clin Gastroenterol Hepatol 2012; 10:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/171\">",
"      Bhattacharya B, Carlsten J, Sabo E, et al. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease. Hum Pathol 2007; 38:1744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/172\">",
"      Dellon ES, Chen X, Miller CR, et al. Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis. Am J Gastroenterol 2012; 107:1503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/173\">",
"      Dranove JE, Horn DS, Davis MA, et al. Predictors of response to proton pump inhibitor therapy among children with significant esophageal eosinophilia. J Pediatr 2009; 154:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/174\">",
"      Molina-Infante J, Ferrando-Lamana L, Mateos-Rodr&iacute;guez JM, et al. Overlap of reflux and eosinophilic esophagitis in two patients requiring different therapies: a review of the literature. World J Gastroenterol 2008; 14:1463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/175\">",
"      Poh CH, Gasiorowska A, Navarro-Rodriguez T, et al. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment. Gastrointest Endosc 2010; 71:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/176\">",
"      Krarup AL, Villadsen GE, Mejlgaard E, et al. Acid hypersensitivity in patients with eosinophilic oesophagitis. Scand J Gastroenterol 2010; 45:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/45/32474/abstract/177\">",
"      Schroeder S, Capocelli KE, Masterson JC, et al. Effect of proton pump inhibitor on esophageal eosinophilia. J Pediatr Gastroenterol Nutr 2013; 56:166.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2243 Version 22.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-92133E1D40-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_45_32474=[""].join("\n");
var outline_f31_45_32474=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1536290\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1536312\">",
"      Environmental factors and T-cell immunity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1536355\">",
"      Genetic factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H582018\">",
"      Clinical manifestations in adults",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H582242\">",
"      Clinical manifestations in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H582285\">",
"      ASSOCIATIONS WITH OTHER DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1679777\">",
"      Endoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1680258\">",
"      Histology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18297054\">",
"      Radiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18297061\">",
"      Laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1681291\">",
"      Evaluation for allergies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18301880\">",
"      Therapeutic trial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18302596\">",
"      Other diagnostic tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Distinction from GERD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18301888\">",
"      Proton pump inhibitor-responsive esophageal eosinophilia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2243\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2243|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?35/45/36575\" title=\"picture 1\">",
"      Eosinophilic esophagitis Endosc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?31/2/31791\" title=\"picture 2\">",
"      Eosinophilic esophagitis rings CPC Endosc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?22/23/22896\" title=\"picture 3\">",
"      Eosinophilic esophagitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?31/10/31910\" title=\"picture 4\">",
"      Eosinophilic esophagitis CPC Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?32/27/33214\" title=\"picture 5\">",
"      Eosinophilic esophagitis barium swallow",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/58/29606?source=related_link\">",
"      Boerhaave's syndrome: Effort rupture of the esophagus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/57/10137?source=related_link\">",
"      Complications of endoscopic esophageal stricture dilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/12/5321?source=related_link\">",
"      Diagnostic evaluation of food allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"./dietary-management-of-eosinophilic-esophagitis?source=related_link\">",
"      Dietary management of eosinophilic esophagitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/37/40535?source=related_link\">",
"      Diseases with eosinophilic involvement of specific organs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/43/43703?source=related_link\">",
"      Eosinophilic gastroenteritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/55/32633?source=related_link\">",
"      Overview of skin testing for allergic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?38/54/39778?source=related_link\">",
"      Patient information: Eosinophilic esophagitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?21/0/21506?source=related_link\">",
"      Patient information: Upper endoscopy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/41/33426?source=related_link\">",
"      Patient information: Upper endoscopy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/8/4231?source=related_link\">",
"      Role of cytokines in the immune system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/58/41897?source=related_link\">",
"      T helper subsets: Differentiation and role in disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/16/44297?source=related_link\">",
"      Treatment of eosinophilic esophagitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_45_32475="Criteria for panic disorder without agoraphobia";
var content_f31_45_32475=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PSYCH%2F69780&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PSYCH%2F69780&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Criteria for panic disorder without agoraphobia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        A. Both (1) and (2):",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        (1) Recurrent unexpected Panic Attacks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        (2) At least one of the attacks has been followed by 1 month (or more) of one (or more) of the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        (a) Persistent concern about having additional attacks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        (b) Worry about the implications of the attack or its consequences (eg, losing control, having a heart attack, \"going crazy\")",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        (c) A significant change in behavior related to the attacks",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        B. Absence of Agoraphobia",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        C. The Panic Attacks are not due to the direct physiological effects of a substance (eg, a drug of abuse, a medication) or a general medical condition (eg, hyperthyroidism).",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        D. The Panic Attacks are not better accounted for by another mental disorder, such as Social Phobia (eg, occurring on exposure to feared social situations), Specific Phobia (eg, on exposure to a specific phobic situation), Obsessive-Compulsive Disorder (eg, on exposure to dirt in someone with obsession about contamination), Post-Traumatic Stress Disorder (eg, in response to stimuli associated with a sever stressor), or Separation Anxiety Disorder (eg, in response to being away from home or close relatives).",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_45_32475=[""].join("\n");
var outline_f31_45_32475=null;
var title_f31_45_32476="Causes of hyperthyroidism";
var content_f31_45_32476=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F76972&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F76972&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of hyperthyroidism",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Hyperthyroidism with a normal or high radioiodine uptake",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Autoimmune thyroid disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Graves' disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hashitoxicosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Autonomous thyroid tissue (uptake may be low if recent iodine load led to iodine-induced hyperthyroidism)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Toxic adenoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Toxic multinodular goiter",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        TSH-mediated hyperthyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        TSH-producing pituitary adenoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Non-neoplastic TSH-mediated hyperthyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Human chorionic gonadotropin-mediated hyperthyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hyperemesis gravidarum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Trophoblastic disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Hyperthyroidism with a near absent radioiodine uptake",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Thyroiditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Subacute granulomatous (de Quervain's) thyroiditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Painless thyroiditis (silent thyroiditis, lymphocytic thyroiditis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Postpartum thyroiditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Amiodarone (also may cause iodine-induced hyperthyroidism)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Radiation thyroiditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Palpation thyroiditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Exogenous thyroid hormone intake",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Excessive replacement therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Intentional suppressive therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Factitious hyperthyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Ectopic hyperthyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Struma ovarii",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Metastatic follicular thyroid cancer",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Major causes of hyperthyroidism according to the presence of a high or low radioiodine uptake. High uptake indicates increased new hormone synthesis by the thyroid whereas low uptake indicates release of preformed hormone, exogenous ingestion, or extrathyroidal hormone synthesis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_45_32476=[""].join("\n");
var outline_f31_45_32476=null;
var title_f31_45_32477="Etiology syncope men women";
var content_f31_45_32477=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F77511&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F77511&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Causes of syncope in men and women",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 384px; height: 283px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Among patients with syncope, men are more likely to have a cardiac cause, while women are more likely to have a noncardiac cause or syncope of unknown etiology.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Freed LA, Eagle KA, Mahjoub ZA, et al. Am J Cardiol 1997; 80:1183.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_45_32477=[""].join("\n");
var outline_f31_45_32477=null;
var title_f31_45_32478="Greenstick fracture";
var content_f31_45_32478=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F69866&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F69866&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Greenstick fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 317px; height: 371px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Greenstick fractures of radius and ulna in a 6-year-old boy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paula Schweich, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_45_32478=[""].join("\n");
var outline_f31_45_32478=null;
var title_f31_45_32479="ERCP biliary leak post LT";
var content_f31_45_32479=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F82625&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F82625&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bile leak following liver transplantation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 449px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This is a classic ERCP for a biliary leak in a patient after a liver transplant. The arrow is pointing to the area of extravasation of contrast from the biliary tree.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Karen Krok, MD and Paul J Thuluvath, MBBS, MD, FRCP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_45_32479=[""].join("\n");
var outline_f31_45_32479=null;
